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SUMMARY
The biochemistry and physiology of the renin- 
angiotonsin system in vertebrates is reviewed. 
Techniques Tor measuring some components of* this 
system have been developed. The intention was to 
develop techniques that could be applied to studies 
in most if not all vertebrates.
Unlike mammalian renal renin, it was not 
possible to bioassay renal renin of fish, amphibia, 
reptiles and birds simply with the rat blood pressure 
preparation. It was necessary to develop enzyme 
kinetic techniques based on the hydrolytic action 
of the enzyme renin on its protein substrate to 
form the vasopressor peptide angiotensin.
Angiotensin is destroyed in all tissues and 
body fluids by peptidases (angiotensinases)• In 
developing these techniques it was important to 
inactivate angiotensinases and this aspect was 
considered at length. Many enzyme poisons were 
tested and often their effectiveness was pH- 
dependent. Diisopropyl phosphite (DP) inhibited
ix
kidney angiotensinases satisfactorily in most of 
the ^0 vertebrate species that were studied.
These vertebrates included representatives from 
the five major classes. DP also inactivated 
angiotensinase in eel (Anguilla an^uilla) plasma 
and the eel corpuscle of Stannius. In other 
studies with fish and mammalian plasma, 
angiotensinases were also effectively inhibited 
by a combination of phenanthroline and ethylene 
diamine tetra acetate.
The optimal conditions for the enzymic 
reaction of renin were considered and it was 
found that some properties of the fish renin 
reaction differ from those established in mammals. 
The eel renin reaction with eel renin—substrate 
was optimal at 20°C and a lower pH (5.k). Also 
eel renin was inactivated at a pH above 6.0 •
A simple method for the bulk preparation of 
ox renin-substrate and its application to the 
assay of renin is described.
Enzyme kinetic techniques for quantitative 
estimation of eel renin and eel human plasma renin 
substrate were developed. Similarly renin was
x
detected qualitatively in the kidneys of 39 out of 40 
vertebrates•
Renin was most concentrated in the posterior 
part of the kidney in the eel and sea trout (Salmo 
trutta) and was detected in eel glomeruli.
The renal renin and plasma renin-substrate ,
concentrations were compared in eels adapted to 
seawater or freshwater. Renal renin concentration 
did not differ significantly but plasma renin- 
substrate was marginally higher (p = < 0 .l) in 
freshwater adapted eels. Eel plasma renin-substrate 
concentrations were similar to human plasma 
concentrations. In the human, the influence of 
some clinical conditions, pregnancy and oral contra­
ceptives were assessed.
The content of renin in eel corpuscles of 
Stannius was less than that in the eel kidney and 
this may have been due to contamination during their 
removal from the kidneys. The potent vasopressor 
substance known to be present in these organs remains 
unidentified.
A role of renin in the regulation of water and 
electrolytes in fish is discussed finally.
xi
11. GENERAL INTRODUCTION
1*1* The need to control the osmotic 
pressure of body fluids; 
phylogenetic considerations.
The earliest form of life is thought to have 
been unicellular and to have arisen in the sea* 
Essential nutrients and oxygen entered the cell by 
diffusion from the surrounding aquatic medium and 
waste products were excreted by the same route* 
Evidence from present day unicelluler organisms 
suggests that the high intracellular potassium and 
low intracellular sodium concentrations, vital for 
normal animal cell metabolism, were maintained 
against concentration gradients by energy-consuming 
or active processes. The evolution of multi- 
cellular organisms, in which each cell was not 
directly in contact with the external environment, 
necessitated the elaboration of a circulatory 
system, at first open and later closed, to 
distribute nutrients to tissues and to remove 
metabolites. The electrolyte composition and
2osmotic pressure of the circulating extracellular 
fluid is thought to have been based on the marine 
environment prevailing at that time. The 
metabolism of the tissues is adapted to this 
pseudo—marine environment, the extracellular 
fluid and is markedly affected by relatively small 
changes in the concentrations of sodium and 
potassium ions, osmotic pressure, pH, and many 
other factors. The character of extracellular fluid 
must therefore be maintained within narrow limits.
The osmotic characteristics of extracellular 
fluid may be altered either by changes in 
electrolyte content or by the gain or loss of water. 
An obvious means of preventing changes in these 
factors is to construct an impervious pellicle 
around the animal, thus inhibiting physical and 
chemical intercourse with the environment. 
Unfortunately, certain surfaces must be excluded 
from this protection in order to allow such processes 
as gaseous exchange and excretion to continue. Xt 
is at these surfaces, such as gills, renal tubules 
and intestinal mucosa, that the animal becomes 
vulnerable to salt and water imbalance.
3From the time at which the concentration of 
the extracellular fluid was fixed to the present 
day, the concentration of sea water has increased. 
Terrestrial animals have the added problem of 
water conservation. Thus organisms living in each 
of the major habitats - marine, terrestrial and 
freshwater - are presented with different problems 
of maintaining the concentration and composition 
of their body fluids.
Marine animals, living in.a hyperosmotic 
environment, tend to gain sodium by diffusion, for 
example at the gill surfaces, but lose water. This 
process must be reversed by the active expulsion 
of sodium ions. In freshwater, conversely, loss of 
sodium to the hypo-osmotic environment with water 
influx tends to disturb osmotic equilibrium. In this 
case, sodium must be actively retained, A number 
of fish migrate between marine and freshwater 
conditions and must therefore alternate between 
these extreme situations. Finally, terrestrial 
animals excrete large volumes of water containing 
not only the toxic waste products of metabolism 
but also variable quantities of electrolytes,
kparticularly sodium. Like freshwater animals, 
therefore, they may need to retain sodium.
In vertebrates, a major organ of osmo­
regulation is the kidney. Renal electrolyte and 
water excretion is affected by many factors, both 
neurological and endocrine. Teleologicaliy, however, 
it seems logical that the kidney itself may have 
a primary role in controlling excretion. This role 
may be partly accomplished by the renin - angiotensin - 
aldosterone system, and it is with this system that 
the following thesis is concerned.
1.2. The renin - angiotensin -
aldosterone system. (fig l)*
Renin, a renal enzyme is released into the blood 
stream where it catalyses the hydrolysis of a plasma 
protein substrate to the decapeptide angiotensin 1 . 
Angiotensin I, with no known direct physiological 
actions, is further hydrolysed to the octapeptide, 
angiotensin II, under the control of converting 
enzymes which are present in plasma and also in many 
tissues. The properties of these components are 
discussed in detail in section 2.
5Fig»l. The biochemistry and physiology of* the renin- 
angiotensin system*
SUBSTRATE
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Angiotensin XX maybe an important element in 
the control of blood pressure and sodium balance. 
Evidence suggests that angiotensin II may 
mediate either sodium retention or sodium 
excretion by a direct effect on the kidney 
depending upon the prevailing sodium status of the 
organism (see review by Brown et al, 1971b). Also 
blood pressure increases markedly in sodium-loaded 
human subjects infused with angiotensin, thus 
increasing glomerular filtration and sodium 
excretion. Infusion in sodium deplete subjects on 
the other hand has less effect on blood pressure. 
Angiotensin infusion also leads to an increase in 
the secretion and plasma concentration of 
aldosterone (see reviews by Fraser et al, 1969;
Brown et al, 1971b), a sodium-retaining cortico­
steroid which acts on the distal renal tubule. 
Angiotensin II does not affect aldosterone secretion 
so markedly in sodium-loaded subjects. Angiotensin 
II may have further effects on ADH release (Bonjour 
and Malvin, 1970; Mouw et al, 1971; Tagawa et al,
1971)» and thirst (Brown et al, 1969; Fitzsimonds,
1972).
7As will be discussed, the precise role of the 
renin-angiotensin system in lower vertebrates 
remains unclear, partly through lack of reliable 
techniques for measurement of the various 
components. Evidence in man (Gould and Green, 
1971; Helmer and Judson, 1967) suggests that the 
concentration of angiotensin XI present in the 
circulating blood will depend upon the concentr­
ations of both renin and renin-substrate. The 
following thesis is an account of an attempt 
to construct and evaluate methods of measuring 
renal renin and plasma renin-substrate (section Z) 
and the use of these methods to study the renin- 
angiotensin system in a variety of species paying 
particular attention to the migratory eel 
Anguilla anguilla. . .
82. METHODS OF STUDYING THE RENIN- 
ANGIOTENSIN SYSTEM.
2*1* Introduction
In order to study the renin-angiotensin system 
it is first necessary to measure each of its 
components in blood or plasma and possible also 
in tissues. To develop these methods, careful 
attention must be paid to the physical and 
chemical properties of the individual components. 
These are described below.
2.1.1 Properties of the components of the renin- 
angiotensin system.
2.1.1.1 Renin.
Knowledge of the physical characteristics of 
renin is rudimentary and studies on it have mainly 
been confined to mammals. Though it is known to be 
a protein and enzyme, it has yet to be isolated 
in crystalline form. Several partial purifications 
have been reported (Nairn et al, i960; Haas et al, 
1965» Peart et al, 1966a; Lubash & Peart, 1966;
9Maier & Morgan, 1966; Skeggs et al, 1967?
Newsome, 1969? Rubin, 1972). Properties vary 
slightly from species to species. For example, 
the molecular weight of both human and porcine 
renin is approximately 40,000 (Warren and 
Dolinsky, 1966; Rubin et al, 1966; Peart et al, 
1966a) whereas that from the marsupial 
Trichosurus vulpecula is heavier at 53>000 (Reid 
and McDonald, 1969b). Although similar in 
molecular weight, porcine and human renins have 
different chromatographic mobilities on starch gel 
(Peart et al, 1966 b) and there may be several 
different renins from the same species (Skeggs 
et al, 1967; Rubin, 1972).
Renin must therefore be recognised by its 
biochemical properties. It is classed as a 
peptidohydrolase (E.0.3*4.4.15) which catalyses- 
the hydrolysis of the leucyl-leucine bond in 
the renin-substrate molecule (Skeggs et al, 
1957»1958). Biochemical properties, which are 
more readily studied in impure preparations have 
.received more detailed attention. The enzyme is
10
stable indefinitely either at —20° or in a 
lyophilised state. Dimercaprol and ethylene 
diamine tetra acetate (EDTA) which chelate various 
metal ions, do not affect its activity (see Lee, 
1969)* indicating that it is probably not a 
metalloenzyme• Further studies (see section 2) 
tend to corroborate this finding. Sulphydryl 
reagents such as para-chlorobenzoic acid or salts 
of cadmium or mercury are without effect on the 
activity of the enzyme unless used in high 
concentrations for long periods (see Lee, 1.969)*
This suggests that sulphydryl groups are not 
components of the active site but may have an 
important role to play in maintaining the overall 
tertiary structure of enzyme protein. However, 
other heavy metal ions such as zinc and copper may 
cause inactivation (Lee 1969)* Renin is also 
inhibited by sodium deoxycholate, present in bile 
(Hiwada et al, 1971) and n-heptane (Haas and 
Goldblatt, 1961). The active centre contains no 
serine. Small quantities of di-isopropyflouro- 
phosphate (DFP), which esterifies the free hydroxyl 
of serine, do«e not reduce the activity of the enzyme
11
(Pickens ©t al, 1965)*
It is probably stored in an inactive form since 
acidification in the region of pH 3*5 of renal tissue 
(llubin, 1972; Leckie, personal communication) and 
amniotic fluid (Lumbers, 1971) increases its 
activity.
Stability in acid solution varies with species 
and also with the purity and concentration of the 
preparation. Canine plasma renin is not inactivated 
toggreat extent by pH levels as low as 2.5 during 
its extraction, even at room temperature for 
several hours (Brown et al, 1964b). However, 
partially purified or dilute solutions of renin 
extracts are less stable (Peart et al, 1966a). At 
0° it is less stable in alkaline (pH 10) than in acid 
(pH 4) solution (Pickering and Prinzmetal, 193&). 
Further investigations of the effect of pH on 
renin activity are described in section 2.2.4.
2.1.1.2. Other renin-like enzymes 
A number of enzymes other than renin hydrolyse 
renin-substrate. Among these are the less 
specific peptidases such as pepsin (Weber et al, 1942; 
Croxatto <§» Croxatto, 1942; see also Lee, 1969)* One
12
of the products of the reaction of pepsin with 
renin-substrate has been characterised as 
angiotensin I (Franze de Fernandez et al, 1965)* 
However, pepsin is readily distinguishable from 
renin by its lower pH optimium and also because it 
is inhibited by poly—1-lysine and is inactivated 
in neutral or alkaline solution whereas renin is 
not (Lumbers and Skinner, 1969)* These 
differences have been employed in methods of * 
preparing renin.
Perhaps more interesting is the probable 
existence of isoenzymes of renin, Renins have been 
isolated from many tissues including lung, liver, 
blood vessel walls, spleen, amniotic fluid, 
subrnaxillary gland and brain (Gould et al* 1964; 
Skeggs et al, 1969; Taiceda et al, 1969; Symonds 
et al, 1970» Carretero and Houle, 1970; Lumbers 
1971» Johnson et al, 1971; Eskildsen, 1971;
Ganten et al, 1971; Carretero et al 1971)• Renin 
isolated from rabbit uteri#and placenta is probably 
identical with the renal enzyme from this animal 
(Ziegler et al, 1967; Ryan, 1970). However, 
renin from the dog uterus, though having several
similar properties to renal renin, was able to 
digest another plasma substrate (Carretero and 
Houle, 1970), Human pseudorenin (Skeggs et al, 
1969) obtained from kidneys and plasma could be 
separated from human renin by DEAE cellulose 
chromatography. It was inactive in serum but prod 
uced angiotensin from tetradecapeptide and 
substrate A (see below). The pH optimum for this 
reaction was lower than renin,
2,1.1,3* Renin-substrate
Renin-substrate is an alpha—2-globulin 
(Plentl et al, 1943; Cohn et al, 1944,) which is 
most abundant in plasma but present also in 
lymph (Friedman et al, 1943; Lever and Peart, 1962 
Horky et al, 1971)• In common with many other 
plasma proteins it is probably synthesised in the 
liver since removal of this organ or hepatic 
necrosis results in a marked and rapid decrease 
in plasma renin-substrate concentration (Page et 
al, 1941; Gould et al, 1966; Ayers, 1967)* 
However, its concentration in the hepatic vein 
of rats was not higher than peripheral veins 
(Dauda et al, 197G) nor has it been isolated from
hepatic tissue or indeed from any other tissues 
(Munoz et al, 1940).
Renin—substrate is stable for several years 
o
at -20 • Degradation is accelerated in acid 
conditions (Dexter et al, 1945? Skinner, 1967). 
Increasing the ionic concentration of the substrate 
solution, for example with sodium chloride, 
prevents damage in acid conditions (Dexter et al, 
1945| Lever et al, 1964).
Renin-substrate may not be a single compound 
but a complex mixture of proteins and/or 
glycoproteins (Skeggs et al, 1957* 1953, 1964). 
Gradient elution from diethyl-amino-ethylene 
cellulose (DEAE) columns with sodium acetate 
(pH 5.6 down to 4.0) is reported by Skeggs and 
his co-workers (1964) to separate porcine plasma 
renin—substrate preparations into at least five 
fractions, three of which are glycoproteins 
(A,C, C2) of similar molecular weight (57>000) 
and which are hydrolysed with equal efficiency 
by renin* These and other protein substrates 
(B,D,E and synthetic tetradecapeptide) are attacked 
at similar rates by renin. Some doubt has been
15
cast upon the validity of these results by the 
inability of later workers to confirm them. Using 
a different buffer to gradient elute from DEAE 
cellulose, Cook and Lee (1965) could find no 
evidence of more than one component, and it is 
suggested (see Lee, 1969) that some degradation 
may have occurred in the Skeggs preparation, 
possibly during the stages of the extraction 
where low pH levels were used. However 
Nasjletti et al (l97l) using starch-gel 
electrophoresis found substrate in the albumin 
a n d ^ 2 globulin fractions.
In the past,interest in plasma renin—substrate 
has been restricted largely to preparing it in a 
suitable form for use in assays of renin. 
Frequently, this has meant little more than the 
addition to substrate-containing plasma of various 
inhibitors of angiotensinase (see 2.1.1.6. and 
section 2.2.2.) and converting enzymes (see 
section 2.1.1.7*)* A synthetic totradecapeptide 
substrate has also been prepared (Skeggs et al, 
1956) hut this has the disadvantage that it may 
decompose to angiotensin spontaneously (Skeggs et 
al, 1969).
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In section 2.2.4. methods of measuring plasma 
renin-substrate are described and discussed. 
Preparations for use in the assay of renin are 
dealt with in section 2 .2 .3 *
2 .1 .1 .4. Renin-renin-substrate 
specificity.
Renin from a given species may vary in its 
ability to hydrolyse renin-substrate from other 
species. This suggests that protein moiety of the 
substrate molecule from which angiotensin X is 
detached varies from species to species and that, 
although renin is capable of releasing 
angiotensin from relatively small polypeptides 
(see 2 .1 .1 .3 * above), in plasma, the character of 
this protein moiety influences the rate of 
hydrolysis. As discussed (in 2.1.1.1.) 
variations in the structure of renin may also 
account for part of the variation in reaction 
rate.
The relationship of the structure and 
specificity of renin and its substrate to the 
position of a particular species on the
17
evolutionary scale is a subject which has received 
very little attention to date but which would 
make an interesting and possibly rewarding 
study* The available information is confused*
For example, although it was originally stated 
that only primate renin was capable of releasing 
angiotensin from human plasma renin-substrate 
(Fasciolo et al, 19^ -0 ) , more recent studies 
(Arakawa et al, 1965) using an improved method of 
assaying angiotensin demonstrated that rat, porcine 
and bovine renin also act but with somewhat lower 
affinity than human renin* Conversely, human 
renin has a very low affinity for rat substrate.
A similar situation exis.ts between the chicken 
(presumably Gallus domesticus) and toad (Bufo
arenarum and J3* paracnemis)j toad renin releases
>
angiotensin from chicken plasma renin-substrate 
but the converse does not occur (Nolly and 
Fasciolo 1971 a). Amphibian renin has a very low 
affinity for mammalian substrate (Johnston et al 
1967b, Nolly and Fasciolo, 1971a), though 
Capelli et al (197^) could detect renin in Rana
18
pipiens kidney on incubation with calf (Bos taurus) 
substrate. Simpson and Blair-West (1971 and 1972) 
have suggested that marsupial renin-substrate may 
differ from purified and synthesised substrate 
(as in figure 2). They demonstrated that whilst 
antibodies to angiotensin XI would react with 
marsupial angiotensin XI, antibodies to 
angiotensin I would not react with marsupial 
angiotensin I. This suggested that amino acids 
9 and/or 10 may differ in the marsupial renin- 
substrate.
2.1.1.5. Angiotensin
The term "angiotensin" is used to describe
both the decapeptide angiotensin I and the
octapeptide angiotensin II. The relationship
between these and converting enzyme (see 2.1.1.6.)
>
is described in section 2.1.1.1. and illustrated 
in figure 1 and 2. Angiotensin II differs from 
angiotensin I by the lack of a histidyl-leucine 
dipeptide at its C-terminal end. Two forms of 
angiotensin are known to occur in nature. Valine 5 
angiotensin I and II was first isolated from an 
equine plasma renin-substrate preparation treated
STRUCTURE of RENIN-SUBSTRATE
and ANGIOTENSIN
Asp1
i «Arg*
Val3
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lieu5 (or Val5)
His6
Pro7i
Converting ^  Phe8_______________
Enzyme His9
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Renin --------► -+—n------------------------------------Leu11
vii12
Tyr13
Sir14
i
Remainder 
of substrate 
molecule
Fi&*2. (After Skeggs et al, 1955,*56 
and Peart and Blliott, 1957).
Angiotensin 1
,'57,'58
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with porcine renin by Skeggs ot al (1954, 1955»
1956 b and c), Xt was characterised by Lentz et
al (1956a)• At the same time, Peart (l955» 1956)
and Elliott and Peart (1956, 1957) purified
isoleucine 5 angiotensin I from bovine substrate
incubated with rabbit renal renin. Since then
a number of other forms have been synthesised
(see Page and McCubbin, 1968). For example,
the pressor effect of asparagine 1 valine 5
angiotensin II is identical to naturally occurring
angiotensin II, which is also now available
commercially, making it a suitable standard for
bioassay procedures (see sections 2.2,3* and 2,2,4.).
Angiotensin is stable in sterile solution at
low temperature and also in solid form. It is
more susceptible to hydrolysis in alkali than
acid (Dexter et al, 1945; Elliott and Peart,
1957). it can also withstand temperatures as 
ohigh as 100 for periods of several hours,
2.1.1.6, Converting enzyme 
Converting enzyme catalyses the removal 
from the C-terminal end of the angiotensin I 
molecule, of the dipeptibe histidyl-leucine (Lentz
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et al 1956). It d oes not react with the 
nonapeptide formed from angiotensin I by removing 
the C- terminal leucine. Whether a specific enzyme 
for the conversion of angiotensin I to II exists or 
whether the hydrolysis is catalysed by more 
general endopeptidases is the subject of some 
controversy and at present it may be more accurate 
to speak of "converting enzyme activity".
Such activity has been demonstrated in 
equine plasma (Skeggs et al, 1956a) and also 
in homogenates of heart, liver, aorta and ileum 
(Page and Bumpus, 1968). Lung is particularly 
rich in converting enzyme activity and may be the 
source of the plasma enzyme with which it has 
many similarities (Huggins et al, 1970). The 
lung in the dog (Ng and Vane, 1967) and also in 
the rat (Roth et al, 1969) and human (Hollemans 
ot al, 1969) is possibly the major source of 
activity. There is also evidence for a renal 
converting enzyme (Franklin et al, 1970 j Aitlcen 
and Vane, 1972; Leckie et al, 1972) and a 
renal lymph converting enzyme (Horky et al, 1971)•
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This renal enzyme also has similar properties to 
the lung and plasma enzyme though it is 
possibly non-specific for angiotensin I since it 
can hydrolyse bradykinin and other small peptides 
(Yang et al, 1970)•
The optimum pH for converting enzyme 
activity varies from 6.5 to 8 , depending on the 
type of buffer used (Skeggs et al, 1956a) and the 
enzyme is inactivated at pH 3 or below. Xt may 
be a metalloenzyme, or require metal ions possibly 
calcium, zinc, cobalt or manganese (Dorer et al, 1970; 
Huggins et al, 1970; Yang et al, 1970; Fitz et al, 
1971)» for its activity, since both EDTA and cyanide 
(Skeggs et al, 1956a) dimercaprol (Ryan et al, 1966, 
quoted in bee, 1969) dipyridyl (Boucher et al,
1970), phenanthroline (Yang et al, 1970) and 
hydroxyquinoline (Lehfeldt et al, 1971) cause 
its inactivation. Monovalent anions such as the 
halides or nitrate or bicarbonate are also 
required for its activity (Skeggs et al, 195**; 
Piquilloud et al, 1970; Huggins et al, 1970;
Yang et al, 1970).
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The properties of converting enzyme activity 
vary from tissue to tissue* Chelating agents 
inhibit that from lung and plasma (Huggins et al, 
1970» and see above). DFP inactivates that from 
artery walls and also from cardiac muscle leaving 
both plasma, kidney and hepatic enzymes unaffected 
(see Page and McCubbin, 1968; Yang et al, 1970)• 
There are also species specific differences in 
converting enzyme (Poulsen and Bing, 1970)* No 
further studies of converting enzyme have been 
undertaken in this thesis. Further discussion of 
the properties of converting enzyme are to be 
found in the work of Oparil et al (l970)»
Ferreira et al (1970). Piquilloud et al (1970), 
have developed a synthetic substrate for use in 
measuring converting enzyme activity. The 
methods of Huggins and Thampi (196$) and Poulsen 
and Poulsen (l97l) depend on the rate of 
conversion of angiotensin I by plasma.
2.1.1.7* Angiotensinases.
Peptidases which catalyse the hydrolytic 
degradation of angiotensin are generally referred
2k
to as angiotensinases. Xt seems even more probable 
than with converting enzyme that many so-called 
angiotensinases are in fact non-specific plasma 
and intracellular peptidases. The following work 
will therefore refer to "angiotensinase activity"• 
Nevertheless, an examination of the properties of 
these peptidases is of considerable importance 
because methods of measuring both renin and renin- 
substrate rely on the formation of angiotensin, 
and angiotensinase activity must therefore be 
eradicated. In vivo, the length of time that an 
organism is subject to the effect of circulating 
angiotensin is also partially governed by 
angiotensinase. Some peptidases which may not 
affect angiotensin in vivo, may assume great 
importance in vitro. For example, plasma 
pepsinogen is activated to pepsin by acid 
treatment during extraction of renin and may 
interfere with substrate-renin incubations.
The properties of 1angiotensinases1 are the 
subject of reviews by Page and McCubbin (1968) 
and Lee (1969)* Further information is listed in 
Table 1,
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2*1*1*8* Inactivation of angiotensinase 
activity*
Xt is possible to remove angiotensinase 
activity selectively by fractionating plasma and 
tissue extracts using acid treatment and salt 
precipitation (Lever et al, 1964)#
Renin and renin-substrate have been studied 
mainly in renal tissue and plasma* Renal 
angiotensinase activity is effectively eliminated 
by small quantities of DFP (Pickens et al, 1965? 
Yang et al, 1968)* The inactivation of plasma 
angiotensinase activity is more difficult and 
may require combinations of several compounds* 
Ryan et al (1968a, b) used a mixture of two metal 
ion chelators. EDTA, dimercaprol and 
chlorohexidine gluconate an antibiotic, to 
inactivate rabbit plasma angiotensinase activity. 
Inhibitors may also vary in their effectiveness 
depending on the species from which the plasma 
is obtained* Further studies of compounds which 
inhibit angiotensinase activity are presented in 
section 2*2*2* Control of angiotensin in plasma
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and renal extracts from a wide variety of 
vertebrates proved the main technical problem in 
the work undertaken for this thesis; consequently 
it will be considered at length*
2*1*1*9* Renin inhibitors 
Three main types of renin inhibitors have been 
identified*
I* Antirenin,
Antibodies to renin have been raised by inject­
ing partially purified renal extracts into a 
variety of mammals • The resulting antiserum has 
been employed as a means of identifying renin in 
extracts of plasma and to study, by infusing 
antiserum to inhibit renin, the physiological 
properties of renin (see Lee, 1969? Page and 
McCubbin, 1968; Warren and Dolinsky, 1969)* 
Fluorescein-labelled antibodies have been used in 
attempts to locate intrarenal renin in kidney 
slices (Edelman and Hartroft, 1961; Hartroft et al, 
1964), Unfortunately, as previously stated, 
pure renin is not so far available, and thus the
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conclusions of these studies are severely limited* 
Impure renal extracts contain a variety of antigenic 
substances in addition to renin and the use of 
antisera raised to such extracts may cause 
changes unrelated to the presence of antirenin*
II. Phospholipid and other naturally-occurring
renin inhibitors.
Plasma from normal animals may reduce the 
rate of angiotensin formation during incubation 
of plasma samples from nephrectomised animals 
when renin is added to the samples* This 
phenomenon has been demonstrated in both the 
rat (Brunner, 1962) and the dog (Smeby et al,
1967)* The responsible inhibitor has been 
isolated from canine kidneys and identified 
as a phopholipid (Smeby et al, 1967» Sen et al,
1967) and has subsequently been demonstrated 
in plasma and red cells of dog and man (Ostrovsky 
et al, 1967)* Treatment of the phopholipid 
with phospholipase-A produces a lysophospholipid 
with increased renin-inhibiting capacity* It is 
probably this lysophospholipid which causes 
inhibition in vitro* The inhibitor is
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destroyed by phospholipases B,C and D.
Some Information on the properties of* renin 
inhibitors has been obtained indirectly from 
interference by these compounds with techniques 
of measuring renin concentration (see section 2.1 .2). 
For example, Boucher et al (1964) and Pickens et al, 
(1965) found inhibition to occur during incubation 
of plasma extracts, to a degree which varied with 
the source of the plasma. Plasma from uraemic 
human patients suffering from glomerulonephritis 
also decreases the rate of the renin-catalysed 
reaction, presumably due to the presence of an
J
inhibitor (Maebashi et al, 1968). Inhibitors 
may have a degree of species specificity.
Schaectelin et al (1968) demonstrated that vrat 
plasma was capable of inactivating rat renin but 
not hog renin. This inhibitor was inactivated 
by EDTA and also by acidification.
Heparin competitively inhibits the action 
of renin but relatively large quantities ( 5 
to 1900 u/ml) are needed (Sealey et al, 1967)*
The physiological significance of this is
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is questionable* It is possible that heparin or 
some related mucopolysaccharide, located near the 
site of renin biosynthesis, may bind or combine 
with renin, thus rendering it immobile and/or 
inactive* It is known that renin forms 
complexes with mucopolysaccharides such as 
chondroitin sulphate and hyaluronic acid (Haas 
and Goldblatt, 196l)* Alternatively, heparin 
as a polyanion may inhibit renin by 
precipitating some essential colloidal factor 
in plasma*
III. Artificial inhibitors of renin activity 
The effect of heavy metals and organic 
substances that poison renin have been considered 
above in section 2*1.1.1*
2.1.1.10* Factors affecting the rate of 
the renin-catalysed reaction 
Some of the specific factors considered 
above, will affect the reaction of renin with its 
substrate* Also in common with other enzyme- 
catalysed reactions, the action of renin is
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affected by conditions of pH, temperature, and  ^
substrate concentration.
I • Hydrogen ion concentration
The surface charge of an enzyme protein and 
also its tertiary structure and therefore its 
surface conformation, will be affected by the 
pH of the medium in which it is dissolved.
Where, as in the renin reaction, the substrate 
is also a protein, this may also be altered 
by changes in pH. Alterations in surface 
properties of enzyme and/or substrate due to pH 
fluctuation will alter the efficiency with 
which the enzyme can react.
Estimations of the optimum pH for renin vary 
widely from 5*5 to 8 (see Lee, 1969). Since these 
measurements were made on renin-containing extracts 
of variable purity, it is probable that the 
results may have been influenced by the pH 
sensitivity of contaminants. For example, the 
rate of the reaction is measured by the rate of 
formation of angiotensin. Different extracts 
may have contained angiotensinase activity (see
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section 2.1.1*7* ) whose pH optimum differed 
from that of renin. Similarly, the activity of 
inhibitors of renin may be pH-dependent. The 
majority of studies indicate that the optimum 
pH for the renin reaction is approximately 6. 
Further studies are presented and discussed in 
sections 2.2«3« and 2.2.4.2.
XI. Temperature.
The temperature coefficient (Qi q ) an
enzyme—catalysed reaction is approximately 2.
The initial velocity of the reaction increases
with temperature until the enzyme is denatured.
oRenin is denatured at about 35 • As the 
temperature approaches this level, although the 
initial velocity is high, denaturation is marked 
and progressive and the final yield of 
angiotensin is low. The best yields of 
angiotensin are obtained at lower temperature, 
approximately the physiological temperature of 
the animal from which the reactants are obtained. 
This point became of particular importance in 
work on optimal temperature for the reaction of
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eel renin with eel substrate (section 2.2.4.2«).
XII• Substrate concentration
The velocity of enzyme-catalysed reactions 
increases with substrate concentration to a 
maximum (Vmax) which is characteristic of the 
enzyme. The relationship between reaction 
velocity and substrate concentration is used to 
calculate the Michaelis-Menten constant (l^) 
which is a measure of enzyme-substrate affinity. 
Published values of Km for renin vary by over 
three orders of magnitude (see Page and 
McCubbin, 1968), probably again because 
different substrate preparations of different 
purity from different species were used (see 
above). Ideally in measuring renin concentration 
by following the rate of angiotensin formation, 
substrate must be in excess such that the 
reaction rate does not slow to any great extent 
(Section 2.1.2.)• The influence of the 
concentration of renin-substrate in plasma on the 
physiological effect of renin is also discussed 
in section 2.1.2.
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2.1«2. Methods of measuring concentrations of renin 
and renin-substrate in biological materials
2.1.2.1. Renin
I* Introduction
Measurement of the renin content of* tissues has 
presented considerable difficulties, as is 
evident from the long period which elapsed 
between the discovery of the enzyme (Tigerstedt 
& Bergraann, 1898) and the development of 
reliable techniques of measuring its 
concentration in plasma. In the absence of pure 
renin, most techniques have used impure 
standards. Although Goldblatt and his colleagues 
have made available a partially purified, 
lyophilised renin preparation for international 
standardisation, full use has not yet been made 
of it and c> mparison of results between research 
establishments has been difficult. Moreover, 
although the renin content of tissues such as 
kidney may be high and readily detectable by 
biological assay methods, the concentration in 
plasma, a more suitable medium for study, 
particularly in in vivo experiments, is -very low and
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cannot be detected by these means* Techniques 
so far developed can be subdivided into those 
which attempt to measure renin directly and those 
which rely on following the rate of formation of 
the product, angiotensin, of the renin-catalysed 
reaction* For convenience, these have been 
called "direct*' and "indirect" methods respectively*
II. "Direct" bioassay of renin.
The original qualitative test for renin 
(Tigerstedt and Bergmann 1898) was adapted to a 
quantitative method by Pickering and Prinzmetal 
(1938). This relies on a comparison of the pressor 
effect of intravenous injections of renin- 
containing extracts into intact rabbits with the 
effect of a standard renin preparation. Rats are 
now more commonly used for the bioassay* The 
incubation of renin and its substrate occurs in* 
the test animal and the angiotensin released 
increases blood pressure. It is relatively 
insensitive and suitable only for extracts 
containing a large quantity of renin. In common 
with in vitro incubation techniques (see below),
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the exogenous renin and endogenous renin-substrate 
must readily react with each other.
Ill• "Indirect” enzyme kinetic methods
Renin catalyses the formation of angiotensin X 
from renin-substrate (see section l) in vivo and 
in vitro. In common with other enzyme-catalysed 
reactions, the rate of production of angiotensin 
is directly proportional to the concentration 
of renin, providing that substrate concentration 
is not limiting and that conditions such as pH 
and temperature are standardised (Braun—Menendez 
et al, 19^6; section 2.1.1.10). The angiotensin 
produced is most commonly measured by means of 
the rat blood pressure preparation (Skeggs et al, 
1953; Peart 1955) or less satisfactorily using 
strips of artery wall (Heiraer, 1955)* these
preparations angiotensin X is converted to .
angiotensin II which raises blood pressure in 
direct proportion to its mass (section l). More 
recently, techniques of measuring concentrations 
of angiotensin I by radioimmunoassay have been 
developed (Boyd et al, 19691 Poulsen, 1969$ Page 
et al 1969? Haber et al, 19691 Giese et al, 1970),
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which are less time consuming than bioassay and 
have been successfully applied to renin assay. 
Finally, Reinharz and Roth (19&9) have developed 
a synthetic substrate (N-carbobenzoxy-pro-phe- 
his-leu-leu-val-tyr-ser-^3 naphthalamide) which, 
in the presence of renin—containing extracts, 
releases an angiotensin derivative which can be 
measured fluorimetrically.
Since all these techniques depend on 
accurate measurement of angiotensin concentration, 
it is essential that angiotensinase activity should 
be completely inhibited.
Methods for measuring plasma renin are 
generally subdivided according to the way in 
which the renin-substrate is employed. They are 
described as (i) ‘plasma renin activity1 and (ii) 
'plasma renin concentration1 methods respectively,
(i) Plasma renin activity is measured by 
incubating renin in the sample with its endogenous 
substrate under standard conditions. Methods of 
measuring plasma renin activity differ mainly in 
the steps taken to prevent hydrolysis of the 
angiotensin after its formation. In the earliest
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method (Helmer and Judson, 19&3) "the plasma sample 
was merely dialysed at pH 3*5 before incubation 
so that other factors, including converting 
enzyme and angiotensinase were modified as little 
as possible* However, Boucher et al (196^) used 
the metal ion chelating agent, EBTA thus 
inactivating converting enzyme and most angiotensin­
ase. Also the angiotensin formed during 
incubation was adsorbed onto Dowex resin, thus 
both preventing further destruction and also 
concentrating the polypeptide to enhance 
sensitivity in subsequent bioassay. Fasciolo 
et al (1964) used acidification and Pickens et 
al (1963) used EDTA and DFP to obtain complete 
inhibition of angiotensinase activity*
Plasma renin activity methods are rapid 
and convenient and in some cases possess a high
degree of sensitivity. However, they are 
l
subject to a number of severe limitations. For 
example, in no case has the recovery of renin been 
investigated. It has generally been assumed that 
the endogenous concentration of renin-substrate in 
the plasma sample represents an excess and is 
consequently not rate limiting* There is
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evidence that this may not always be so. For
example, Skinner et al (1969) demonstrated that
as a result of therapy with oral contraceptive
steroids, the concentration of renin in the plasma
of human female subjects fell slightly although
plasma renin activity was markedly increased.
These steroid drugs are known to increase the
plasma concentration of a number of proteins
including renin substrate. The results of Skinner
and his colleagues indicate that in the plasma
of the untreated subject, renin-substrate
concentration is a limiting factor in the renin-
cntalysed reacti-on. It may also be a limiting
factor in samples from human subjects with liver
disease (Ayers, 1967)1 and nephrotic syndrome
(Aida et al, 1965; Medina et al 1972). In vitro
studies of the renin-renin-substrate reaction
also point in this way (Gould and ^reen, 1971)•
1
The most recent method of measuring plasma 
renin activity have attempted to circumvent this 
problem by adding exogenous renin substrate 
preparations to the sample before incubation 
(Boucher et al, 1967). Even this manouvre is
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subject to criticism. The majority of measurements 
have been carried out on human plasma, the renin— 
substrate content of* which has been augmented with 
bovine plasma renin substrate. No evidence has 
been presented that the kinetics of* the human 
renin human—renin-substrate reaction and the human 
renin bovine—renin—substrate reaction are identical. 
It is at least possible that the velocity curve 
resulting from this type of* incubation will have 
two components, and that the calculated 1 activity1 
may still largely depend on the initial 
concentration of endogenous renin-substrate.
(ii) Methods of measuring plasma renin 
concentration depend on eliminating substances which 
interfere with the renin-catalysed reaction. These 
include not only *angiotensinases* but also 
endogenous renin-substrate. The plasma extract 
is then incubated with a known quantity of a 
standard renin-substrate preparation.
The earliest of these methods, that of Lever 
et al (1964), removed endogenous renin-substrate 
by means of DEAE cellulose chromatography, and 
inactivated angiotensinase activity by
41
acidification to pH 2.5 or 3 depending on the species 
from which the sample was obtained. The extract 
was then incubated at pH 5*7 with renin-substrate 
prepared from ox blood by acidification and 
fractdtional precipitation with salt. Bovine plasma 
renin substrate preparations were calibrated 
against a standard renin preparation before use. 
Samples taken at intervals from the renin renin- 
substrate incubation were assayed for angiotensin 
by means of the rat blood pressure preparation.
Subsequently other groups have used slightly 
different renin-substrate preparations or have 
inactivated angiotensinase activity with other 
inhibitors. For example, Cook and Lee (1965) 
prepared renin-substrate from nephrectomised 
rabbits, since removal of the kidney increases the 
plasma concentration of this protein. Skinner (1967) 
simplified the procedure for extracting renin from 
plasma, inhibited angiotensinase activity by means 
of KDTA, and prepared renin-substrate from 
nephrectomised sheep. Further studies of renin- 
substrate preparation are presented and discussed 
in section 2.2.5*
Methods of measuring plasma renin concentration 
have the advantage that they are not affected by 
such limiting factors as renin-substrate. With 
such techniques, renin can be studied in isolation, 
whereas renin activity assays may only reveal 
the composite effects of variations in renin, its 
substrate, and inhibitors or accelerators. However, 
renin concentration methods are more elaborate and 
time consuming than the methods of measuring renin 
activity.
XV. Immunoass ay
As previously discussed, (section 2.1.1.9) 
preparations of renin used to raise antibodies are 
as yet too impure to raise specific antisera and 
little progress has been made in measuring 
renin concentration immunologically. The 
situation may possibly be remedied in two ways. 
Investment of time and effort should eventually 
lead to the isolation of renin in uncontaminated 
form for use in immunising animals.
V. Juxtaglomerular index
Ruyter (1925 quoted in Page and McCubbin 1968)
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and Goormaghtigh (1932, 1940 ) observed that renin 
is stored in granules in the renal afferent 
arteriolar - walls• The degree of granulation of 
renal slices — the juxtaglomerular index of JGI — 
can be assessed by light microscopy following 
staining (Bowie, 1935 - 1936) and has been used 
as a semiquantitative measure of renal renin 
(Hartroft. and Hartroft 1953)• The validity of 
this technique obviously depends on equating 
the Bowie—stained granules with renin alone. Only 
circumstantial evidence exists* Granulation is 
increased in animals subjected to physiological 
stimuli (see section 4.1*) which should enhance 
renin biosynthesis (Hartroft and Hartroft, 1953? 
Pitcock et al, 1959; Tobian, i960). Flourescein- 
labelled antirenin (see section 2.1*1*9) is 
bound to the renin-containing granules (Edelman, 
and Hartroft, 1961; Hartroft et al, 1964). Renin 
is not distributed uniformly throughout the 
kidney (see review by Brown et al, 1968) and 
results may therefore vary with the location from 
which the sample is taken*
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2.1.2.2. Measurement of renin-substrate.
Recent evidence suggests that the concentration 
of renin-substrate (angiotensinogen) usually 
present in plasma may have a rate-limiting effect 
on the production of angiotensin by renin (Skinner 
et al, 19^9? Weir et al, 1970a; Brown et al, 1971a; 
Gould and Green, 197l)* Changes of renin-substrate 
may, therefore, influence the amount of angiotensin 
produced by renin* Measurement of the plasma 
concentration of renin-substrate is of interest 
for this reason*
Existing techniques are based on the complete 
conversion of renin-substrate to angiotensin by a 
high concentration of renin, followed by bioassay 
of the angiotensin formed. Methods available for 
man are listed in table 9* Otherwise the 
laboratory rat has been mainly used in studies bn 
renin-substrate (Helmer and Griffith, 1951» 1952; 
Mackaness, 19591 Boucher et al, 1967?
Carretero and Gross, 19^7; Bing and Poulsen, 1969)* 
Data on other mammals and birds, reptiles, amphibia 
and fish is supplied by Schaffenburg et al (i960)
^5
Romero et al (1970) and Nolly and Fasciolo (1971 a 
and 1972) and Mizogami et al (1968).
Although the object of this thesis was to 
study the renin-angiotensin system in vertebrates 
generally, work was begun on a technique for 
measuring renin-substrate in the eel. As will be 
described (2.2,4,1.) it soon became apparent 
that methods available for measuring renin- 
substrate in man were generally unsatisfactory.
As can be seen in table 9» values reported 
for the mean of the normal range for renin- 
substrate concentration in man vary widely from 
one laboratory to another. So great is this 
variation that the upper limit of the normal range 
for some methods (Ayers, 19^7 > Imai and Sokabe,
1968) is below the lower limit of the range 
quoted for others (Maebashi et al, 1965)*
As will be discussed (2,2,5*) differences 
of technique will contribute to this variations 
none of the methods listed (table 9) for man 
reports adequate recovery data, none validates 
the angiotensin standard (see page 114) and ^ew show
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that conversion of substrate to angiotensin is 
complete at the end of incubation.
With these potential sources of error in mind, 
one object of the work reported in section 2.2.5.1. 
of this thesis was to develop and test a method 
for renin-substrate measurement in man. The 
method for renin-substrate measurement in the eel 
(2.2.5*2.) was developed in parallel. Both 
techniques depend on the inhibition of angiotensinase 
activity in the specimen of plasma and in the 
standard renin preparation.
The search for adequate inhibitors of 
angiotensinase activity was a necessary first step 
in the development of renin-substrate assay methods 
for man (2.2.5«i) and the eel (2.2.5*2.) and also 
in methods for measuring renin in kidney extracts 
(2.2.3). The plan of this thesis follows these 
chronological events.
After a preliminary description of the methods 
used (2.2.1) there follows a summary of the testing 
of angiotensinase inhibitors (2.2.2). Information 
gained in these experiments was applied to the
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measurement of renal renin (2,2.3) and renin-
/
substrate (2.2*4*)• In a final section on methods 
(2*2£*) a technique for mass-production of 
renin substrate from the nephrectomised ox will 
be described*
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2.2. New methods developed for
assay of different components 
of the renin-angiotensin system 
in man and other vertebrates
2.2.1 Materials and general methods 
2.2.1.1 Materials 
I . Metal salts
Metal salts used as inhibitors of angiotensinase 
activity (section 2.2.2) were of reagent grade and 
were used without further purification.
IX• Other inhibitors
E-Amino caproic acid, L-arginine and poly-L-lysine 
(molecular weight approximately 175>000) were obtained 
from Sigma Ltd. This firm also supplied 2,2 bipyridine 
and 1,10 phenanthroline which were initially dissolved 
in ethanol (l g / 80 ml.) and further diluted as re­
quired. A 0.4M stock solution of 2•3-dimercaprol ('BAL' 
BDH Ltd.) in arachis oil was also diluted as required. 
Hydrogen fluoride (reagent grade) and sodium ethylene 
diamine tetra acetate ('EDTA*, M & B Ltd.) were used 
as supplied and samples of di-isopropylfluorophosphate 
(DFP' ) were obtained from several sources (Sigma Ltd., 
Koch-Light-Ltd., Kodak Chemical Co. Inc.) to be used 
in ethanol solution (10$ v/v). Diisopropylphosphite 
was obtained from R. Emmanuel Ltd., Koch-Light-Ltd.,
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and the Kodak Chemical Co. Inc., and 'Trasylol*
(a polypeptide) from Bayer Ltd. (Germany).
Ill. Angiotensin
Asn 1 Valine 5 angiotensin II (angiotensin II) 
and asp 1 isoleucine 5 angiotensin I (angiotensin i) 
were obtained from Ciba Ltd. and the Schwarz Bio­
research Co. respectively. S^ock solutions (10 i^g/ral) 
were prepared in buffer (pH 5*7» see below) and further 
diluted for use as a standard in the rat blood pressure 
preparation (0.1 jig/ml.) and for use in the assay of 
human plasma renin substrate (0.1 ^iM).
A solution of natural angiotensin I was also 
prepared using eel renal renin and bovine plasma renin- 
substrate. Eel kidney extract (0.6 ml) and a bovine 
plasma renin-substrate preparation (48 ml. pH 6.2) 
were incubated with diisopropyl phosphite (0.36 ml) 
and buffer (ll ml. pH 6.2) for 15 hours at 37°• The 
mixture was boiled and centrifuged (2,800 r.p.m., 30 
minutes) and the supernatant concentrated at 60° using 
a rotary evaporator. The residue was dissolved in 
buffer solution (2 ml. pH 5»7)« It contained 3*4 pM 
angiotensin (as assayed against angiotensin II).
IV• Buffer solution
Phosphate buffers of various levels of pH were
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prepared by adjusting the proportions of 0 .05M Na^
HPO^ and 0.05M NaH^ PO^ (see Gomori 19^ 55) • The 
total ionic strength of these buffers was maintained 
at 0.15M by adding 0.1M sodium chloride solution.
The buffers were sterilised by boiling and sterility 
was maintained by adding the antibiotic neomycin 
sulphate (0.2 g/lOO ml). Buffers for dialysis pro­
cedures were not sterilised but neomycin sulphate 
was added where stated. Glycine buffers (pH2.5) 
contained glycine (O.IM), hydrochloric acid (3*6 mM) 
and sodium chloride (0.5M).
V . Other substances.
Cabbage phospholipase C and phospholipase D from 
Clostridium perfringens were supplied by Koch-Light- 
Ltd. and soya bean trypsin inhibitor by Sigma Ltd.
Sea water (SG 1.022) was prepared by dissolving a salt 
mixture ('Meeresalz' Aquatic Hobby Ltd.) in Glasgow tap 
water.
VX• Equipment
Syringes (Hamilton Co.) of 250 jil and 100 i^l 
capacity were used for general bioassay purposes and 
for estimation of plasma renin substrate (section 2.2.4) 
respectively. Incubations of renin extracts and renin- 
substrate were performed in polyethylene tubes (10 ml,
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Nalgene) and aliquots from these were stored in clip- 
top polythene tubes (5 ml, A.R. Horwell Ltd.).
VII. Animals
Live eels (Anguilla anguilla L .) were obtained 
principally from Loch Lomond and supplied by Mr. ¥. 
Greene of Glasgow. Other sources were the University 
of Glasgow Research Station, Rowardennan, Stirling­
shire; Freshwater Biological Association, Ambleside, 
Westmoreland; and Messrs. Brammer and Morck Ltd., 
Billingsgate, London. Prior to use they were kept 
out-of-doors in a fibre glass tank (6* x 3* and 2.5') 
through which tap water was running constantly.
During experiments one or two eels were kept in 70 
litre polythene, tanks containing either tapwater or 
seawater. In each case, the water was circulated by 
means of an Eheim pump and filtered through a charcoal 
resin filter. The pH of the water was tested at 
frequent intervals (sea water - pH 8, tap water - pH7) 
-and the charcoal/resin filter changed when pH fell by 
one unit. This restored pH to its initial level.
Rats (Wistar) used for the bioassay of renin and 
angiotensin were supplied by Oxfordshire Laboratory 
Animal Colonies and were prepared for use as described 
by Peart (l955)« Kidneys from a variety of vertebrates, 
supplied by the Zoological Society (London), were stored
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at - 20°.
2.2.1.2. General Methods
I . Preparation of renin substrate
Bovine renin-substrate Tor the assay of renal
renin was prepared by the method of Lever et al (196^)*
Its preparation varied slightly with the purpose for
which it was intended. It was prepared from plasma
from nephrectomised stirks (castrated bulls) for use
in the assay of renal renin. The renin-substrate
concentration (l.l6 jaM) was determined from replicate
incubations with an excess of human renin. When used
to study the inhibition of angiotensinase activity it
was diluted to 0.58 jiM, In each case, it was stored 
oat - 20 • Further studies of bovine renin substrate 
preparation are presented in section 2.2.5*
Human renin-substrate was prepared according to Dexter 
et al (19^5) with the following modification. After 
the final centrifugation, it was dialysed against pH 
6.8 phosphate buffer for 2k hours at k°C and diluted 
in the same buffer to a renin substrate concentration 
of 123 nM. At this concentration there was no detec­
table angiotensinase activity.
H . Extracts of kidney and corpuscles of Stannius
Samples of kidney from several species and cor-
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puscles of Stannius from the eel were macerated in 
phosphate buffer (pH 5«7, 5 ml/g tissue) with a 
pestle and mortar and acid-washed sand (40-100 mesh,
BDH). After standing at room temperature with frequent 
mixing for one hour, the supernatant was removed by 
centrifugation and stored at - 20°. It was recentri­
fuged on each occasion when it was thawed to remove 
precipitates.
An extract of a large number of eel kidneys was 
prepared in a similar manner for use in the study of 
the inhibition of angiotensinase activity (section 2.2.2) 
and in the development of a method for the assay of eel 
renal renin (section 2.2.3)•
III. Human renal renin. Human renal renin was prepared 
by the method of Brown et al (1964s). It was diluted in 
sodium phosphate buffer (pH 5*7) to a concentration of 
10 units/ml (one unit of renin, incubated with ox sub­
strate forms 100 ng angiotensin/ml/hr) and stored at -I
20°. Under these conditions it is stable for at least 
six years.
IV. Exsanguination procedures.
Blood for renin and renin substrate assay (section
2.2.4, 2.2.5, 4.2.2) was obtained from eels anaesthet­
ised with MS.222 (2g/l aquarium water, Sandoz Ltd.).
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Blood was collected from the ventral aorta into nylon 
tubes containing lithium heparin (Teklab Ltd.), 
centrifuged and the plasma stored at - 20°.
Blood for the preparation of bovine plasma renin- 
substrate (see above and section 2,2,5) was collected 
from the left carotid artery of an ox previously neph­
rectomised and treated with heparin (3>500 u/100 lb) 
prior to anaesthesis. The animals were respired 
during exsanguination which was kindly performed by 
Dr. J. Campbell of the Veterinary Department, Univer­
sity of Glasgow. Plasma removed after centrifugation 
was either processed immediately or stored overnight 
at 4°.
V. Denaturation of ichthyotoxin
Eel plasma contains a protein which is lethal on 
intravenous injection into other species (Ber.tin 1956 > 
Rocca & Ghiretti 1964). This toxin was denatured by 
immersing incubated plasma extracts in boiling water 
in a tightly sealed polythene tube for five minutes 
(see also section 2.2.5). The protein precipitated 
during this procedure was removed by centrifugation.
VI• Bioassay of angiotensin
Angiotensin in incubation media was assayed by 
means of the rat blood pressure preparation (Peart 1955).
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The limit of the assay is determined by the responsive­
ness of the rat to angiotensin* The threshold response 
occurs at approximately 1 ng (0*97 nm)of angiotensin XX 
contained in 0.1 ml of solution.
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2,2.2. Inhibition of angiotensinases
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2.2.2.1. Introduction
Extracts of biological tissues containing renin 
and renin-substrate are invariably contaminated with 
angiotensinases. Since neither renin nor its substrate 
can be measured in their presence, a necessary first 
step in developing methods of measuring renin or 
renin-substrate is the removal or inactivation of 
these angiotensinases. This section is concerned, with 
the different problems of inhibiting angiotensinase 
activity in renin-containing extracts of kidneys, plasma 
and other tissues from a wide variety of vertebrates.
In general, enzyme activity can be inhibited by:-
(i) removing an essential cofactor
(ii) competitive inhibition using compounds 
resembling the substrate of the enzyme.
(iii) selective protein denaturation.
With these principles in mind, the inhibition of angio­
tensinase activity has been attempted by displacing 
essential metal ions, either with heavy metal salts or 
with metal ion chelating agents. Amino acids and amino 
acid analogues have been tested as possible competitive 
inhibitors, and organophosphorus compounds and sulphy— 
dryl reagents have also been employed in an attempt to 
inactivate the active centre of the enzymes.
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Finally, the effect of mild protein denaturing tech­
niques has also been investigated. Compounds were 
tested not only as inhibitors of angiotensinase 
activity but also for undesirable side-effects such as 
renin inactivation and toxicity to the rat during the 
bioassay of angiotensin.
2.2.2.2. Assessment of angiotensinase 
activity.
I . Hydrolysis of synthetic angiotensin I and II
Angiotensinase activity results in reduced 
recoveries of angiotensin when incubated with tissue 
extract. The efficacy of inhibitors of angiotensinase 
activity was tested by comparing the recovery of angio­
tensin I or angiotensin II (100 ng/ml incubation medium) 
from incubated extracts containing inhibitor with that 
from control incubation lacking inhibitor. In all 
cases, the same type of angiotensin was used for the 
incubation and for the bioassay standard.
II• Natural angiotensin
Recoveries of endogenously-formed angiotensin 
were also studied in control experiments by incubating 
renal extracts with ox renin-substrate with and without 
inhibitor. In this case, absence of angiotensinase 
activity was indicated by a gradual rise in angiotensin 
concentration during incubation, reaching a maximum
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I g v g I  which was then maintained until the incubation 
was terminated. Angiotensinase reduced the rate of 
increase of angiotensin and, when the maximum concen­
tration had been reached, caused a gradual fall in 
concentration until the incubation was terminated 
(see Lever et al, 1964).
III. Estimation and expression of recovery
Renal extracts contain little or no renin-substrate 
and, when incubated alone, angiotensin is not formed. 
However, in many species, plasma contains variable and 
appreciable quantities of this substrate. In order to 
correct angiotensin recoveries for angiotensin released 
from endogenous plasma substrate by renin, blank samples 
of plasma were incubated alone. To obtain recovery, the 
blank value was subtracted from that of the sample with 
added angiotensin.
2.2.2.3» Results
Recoveries of added angiotensin from tissue 
extracts incubated in the presence of various inhibitors 
of angiotensinase activity are shown in Tables 2 to 7*
I. Metal ions
Some of the compounds tested improved angiotensin 
recovery from incubated plasma solutions, (Table 2)
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although with salts of zinc, magnesium, manganese and 
barium, the improvement was minimal* Copper sulphate 
and nickel chloride had the most marked effect in both 
human and bovine plasma but mercuric chloride, although 
less effective in human plasma, gave 90$ recoveries 
of added angiotensin from bovine plasma. Unfortunately, 
copper sulphate caused a small amount of protein pre­
cipitation during incubation of plasma. This was also 
true of alum and zinc sulphate, the chlorides of mangan­
ese and barium, and lead nitrate, the extent of precipi­
tation differed between human and bovine plasma.
Although the enzyme properties of the precipitates were 
not tested, they may have contained denatured renin.
None of the compounds tested improved^ angiotensin 
recoveries from human kidney extracts. Since their 
effectiveness on plasma angiotensinases was slight 
and often in combination with protein precipitation 
which might have included renin, no further studies 
were made.
II. Chelating agents
Phenanthroline, bipyridine, ethylene diamine tetra
acetate (EDTA-di-Na), British anti-lewisite (BAL) and
mixtures of EDTA and BAL and of EDTA and phenanthroline
were tested with renal and plasma extracts. The results 
are shown in tables 3 and 4.
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Although phenanthroline Improved angiotensin 
recoveries from incubations of both plasma and renal 
tissue, at concentrations in excess of 1,56 mM it 
reduced blood pressure markedly when injected intra­
venously in the rat.
Bipyridine, even at concentrations as high as 
6 mM, did not have this effect. It inhibited renal 
angiotensinase activity slightly more effectively 
than phenanthroline although this varied with 
species (see below) Bipyridine used at 6 mM caused 
protein precipitation from incubated human and bovine 
plasma, and this was enhanced by frozen storage.
EDTA did not affect the rat blood pressure in 
the range of concentration used in these experiments 
(13 mM) but above this it had a hypotensive effect, 
occasionally. Alone, however, human plasma angioten­
sinase activity was more effectively inhibited by 
phenanthroline or bipyridine, and angiotensinase 
activity in eel kidney extracts was not affected by 
EDTA at all. EDTA (33*6 mM) was most effective when 
used in the plasma of the ox where 70$ of angiotensin 
added remained after 2k hours of incubation. If, 
instead of adding EDTA to the incubation mixture, the 
undiluted plasma was first dialysed against buffer 
containing EDTA (2.7 mM, pH 5*7) before dilution and 
incubation, recovery of angiotensin
64
was improved* BAL (l6 mM) improved angiotensin recov­
eries in human plasma from the control value of 10^ to 
a level of 40^ but further improvement could not bo ob-t
tained. Moreover, protein precijjitation became a 
serious problem at concentrations in excess of 8 mM.
Phenanthroline inhibited canine renal angioten- 
sinases at pH 5*7 and also ox and human plasma angio- 
tensinases (Table 3)• The effects of bipyridine (Table 3) 
were similar.
The effect of pH on angiotensinase inhibition was 
studied with EDTA, bipyridine and phenanthroline. Only 
the two latter substances were effective on eel angio- 
tensinases and then only above pH 7 (fig*3)» Because 
eel renin proved difficult to assay at this pH, the use 
of these chelating agents was abandoned. Also human 
angiotensinases were inactivated by phenanthroline and, 
to a lesser extent, EDTA, in the neutral range (fig.4).
III. Mixtures of chelating agents
It seemed possible that compounds achieving only ^
partial inhibition of angiotensinase activity in a 
given tissue extract might, when used in combinations 
of two or more compounds, cause a more complete 
inhibition. No such synergistic effect was apparent 
using various mixtures of BAL and EDTA in plasma
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II incubated at 37°C. for 16 hours with eel kidney 
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Fig.4. Effect of pH on the recovery of angiotensin 
II incubated at 37°C. for 16 hours with human kidney 
extract (0.5 mg/ml) and with phenanthroline (A» 1.56 
mM) or EDTA (o, 16*7 mM). Each point represents the 
mean of duplicate assays*
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(see Table 4), nor were the undesirable effects of 
the individual components ameliorated by using them 
together*
The most successful combination to inhibit human 
plasma angiotensinase activity was EDTA with phenan­
throline (Figs* 5t 6 and 7)» Also assessing 
angiotensinase activity by the recovery of endogenously- 
released angiotensin (see above), inhibition was 
obtained at pH 6.8 (Fig 6), but marked hydrolysis of 
angiotensin occurred in more acid conditions* This 
combination of angiotensin inhibitors was used 
extensively in studies of human plasma renin-substrate 
(see section 2*2*4*1*)«
The effect of EDTA/phenanthroline varied between 
species as can be seen from figure 7* It consistently 
gave a high recovery of angiotensin I over a wide range 
of pH from bovine, canine and rat plasma extracts*
Indeed, recoveries frequently in excess of 100%* Evidence 
is presented (section 2*2.4.l) that converting enzyme 
activity in the rat blood pressure preparation is 
impaired by repeated doses of EDTA/phenanthroline 
mixture and that a given dose of angiotensin I may 
therefore give a smaller blood pressure response than 
an equimolar quantity of angiotensin II* A possible 
explanation of this recovery in excess of 100$ may
ioo r
•/.
ANGIOTENSIN
n
RECOVERED
50
OL
7-45-7
pH
FigjJj# Effect of pH on the inactivation of human 
plasma angiotensinase by EDTA and phenanthroline. 
Each point represents the mean of duplicate assays 
of angiotensin XX recovered from 20# diluted plasma 
after 24 hours at 37°C. X = EDTA (l3.4mM)j 0 = 
phenanthroline (1.25mM)$A « EDTA (13*4mM; + *phen- 
anthroline (l.25mM).
ANGIOTENSIN 
I  
/iM
0-6
0 4
0-2
4824
HOURS INCUBATION
Fig.6 . Effect of pH on the reaction of human renin 
with human plasma using EDTA and phenanthroline as 
angiotensinase inhibitors. Each point represents 
the mean of duplicate assays. The pH of the incub­
ation mixtures were 5 * 9  ( x ) , 6 . 3  (a ) and 6 . 8  (o).
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150
ANGIOTENSIN
RECOVERY 
at’ 24 hr
50
pH INCUBATION
4
F ig « 7 . Effect of pH on plasma (diluted to 20^) angio- 
tensinase inhibition in several vertebrates by EDTA 
(l3*^niM) and phenanthroline (l»25mM) at 37°C. A = O x,
B m Dog, C ■ Rat, D * Eel, E ■ Cod, F ** Rabbit.
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therefore have been incomplete inactivation of* con­
verting enzyme activity in vitro, Xn the EDTA: 
phenanthroline treated rat, a mixture of* angiotensin I 
and IX may have given an abnormally high blood pressure 
response when compared to an angiotensin I standard,
XV. Acid denaturation.
Xt has been suggested that angiotensinases from 
the kidney of lower vertebrate can be inactivated by 
means of acid treatment for example by dialysis 
against glysine-HCl buffer at pH 2#5 (Capelli, Wesson 
and Aponte, 1970). To test this a number of renal 
extracts were dialysed in this way and were adjusted 
to pH 5*7 before incubation. The results summarised 
in Table 5* Xt is apparent that while acidification 
improved the recoveries of angiotensin from the tissues 
of higher mammals, it was largely without effect in 
those from fish and amphibia. Moreover, it invariably 
caused a voluminous protein precipitate.
V. Organophosphorus compounds.
Organophosphorus compounds combine with the 
primary alcohol group of serine. When this amino acid 
occurs as part of the active centre of an enzyme, the 
activity of the enzyme can be inhibited by organo­
phosphorus compounds. Unfortunately, because of their
Table 5« Inactivation of* kidney angiotensinase 
by acidification to pH 2,p.
Species
Anguilla anguilla 
(eel)
Salmo trutta 
(sea trout)
Rana temporaria 
(frog)
?
(Porters Giant 
tortoise)
Rhea americana 
(rhea)
Phoca vitulina 
(common seal)
Canis familiaris 
(dog)
Rattus norvegioua 
(rat)
Homo sapiens 
(man)
Angiotensin control
Extract $ Angiotensin I
mg/m1 recovered after 2k hr.
0.8 17.5
8.0 10
0.8 20
8.0 10
0.8 30
8.0 15
0.8 70
8.0 50
0 . 8 90
8 . 0 50
0.8 50
8.0 20
0.8 50
8.0 10
0.8 10
8.0 renin response
0.8 87.5
8.0 22.5
90
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potent inhibition of1 nerve function, organophosphorus 
compounds must be handled with extreme caution.
(i) Di-isopropyl fluorophosphate (DFP)
There was a marked variation in the physical 
appearance of* different batches of DFP and also in 
their ability to inhibit angiotensinase activity.
Clear, homogenous or monophasic preparations were 
without effect on angiotensinase activity but were 
lethal to the rat. However, some preparations con­
tained an oily, globular component. These preparations 
inactivated angiotensinase activity in canine and human 
renal extracts at a concentration of 9.6 mM and from
eel kidneys at 14.3 mM over the pH range 3-6.3
(Table 6). The heterogenous appearance of this latter 
type of preparation and also its reduced toxicity in
the rat (see below) suggested that some form of
chemical degradation had occurred and that enzyme 
inhibition was attributable to a derivative rather 
than to DFP itself.
(ii) Products of hydrolysis of DFP
The products of hydrolysis of DFP are 
hydrogen fluoride and di-isoprophyl phosphate. The 
effeots of each of these on angiotensinase activity 
from various sources was tested.
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(a) Hydrogen fluoride.
Hydrogen fluoride was without effect on the 
angiotensinase activity in canine, human and eel 
renal extracts*
(b) Di-isopropyl phosphite*
Di-isopropyl phosphate is not available 
commercially and use was therefore made of the 
phosphite (DP). At a concentration of 36 mM it 
completely inhibited the hydrolysis of angiotensin 
by extracts of eel kidney and eel corpuscle of 
Stannius providing that not more than the equiva­
lent of 1 mg and 4 mg of tissue respectively was 
used per ml of incubation mixture (Table 6).
As is apparent from fig*8, the efficacy of DP in 
©el plasma varied considerably with the pH of the 
incubation medium, but at pH below 5*5 inhibition 
of angiotensinase activity was satisfactory at 18 
hours, the normal period of incubation (see section
2 . 2 .4 . 2 . ) .
Hats used for assay purposes survived repeated 
injections of 0.1 ml of 36 mM DP over a period up 
to 8 hours without exhibiting any adverse effects.
The rat blood pressure preparation has therefore 
been used with DP at a concentration of 36 
Higher concentrations appear to be lethal*
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ANGIOTENSIN
RECOVERED
Fig.8 . Effect of pH on the recovery of angiotensin I 
(o) and II (▲) after 24 hours, from eel plasma (20$) 
with DP as angiotensinase inhibitor. Each point 
represents the mean of duplicate assays.
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For example, ten doses, each of 0.1 ml of 120 mM DP 
administered to a rat at intervals .over a period 
of one hour resulted in its death. As will be des­
cribed (2.2.3), DP has been employed with success in 
the measurement of the renin concentrations in eel 
renin extracts, and also eel plasma renin-substrate 
(section 2.2.4.2.) • DP was also used in studies of 
kidney renin in a wide variety of vertebrates 
(section 4.2.1., Table 12).
VI. Other inhibitors tested
As indicated in Table 7# a further series of 
potential angiotensinase inhibitors were tested and 
found to be ineffective.
2.2.2.4. Discussion of angiotensinase 
inhibition.
The major conclusions of this study were firstly 
that different species and tissues contain different 
angiotensinase8 which are not inhibited by a single 
antagonist and secondly, that the effect!veness of 
a given inhibitor varies markedly with pH.
!_« Renal extracts
DP was of the most general use in the inhibition 
•f angiotensinase activity in renal extracts. The 
efficacy of DP varied with pH, being most effective
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for ©el renin extracts at around pH3« In many circum­
stances, it was less effective than DFP but, since DFP 
is extremely toxic to the rat and man, DP was adopted 
as renal angiotensinase inhibitor at pH below 6 for 
further studies (sections 2.2.3*> and 4.2.). DP failed 
to protect angiotensin in incubations of human and 
canine tissue and in these cases phenanthroline and 
bipyridine respectively were more effective. These 
compounds have previously been employed to prevent 
hydrolysis of bradykinin by plasma peptidases (Erdos, 
Renfrew, Sloane and Wohler, 1963) but not, as far as 
the author is aware, for the inhibition of angiotensin­
ase activity.
II. Plasma angiotensinase
Angiotensinase activity in plasma also contained 
more than one component. Plasma from a majority of 
species contains an EDTA-sensitive fraction. Inhibi­
tion of the remaining activity required the addition 
of a second inhibitor. Although this varied in 
different species, phenanthroline mixtures were used 
In a new technique for measurement of plasma renin 
substrate in man (2.2.4.1 & 3*2.2). To the authors 
knowledge this combination has not been used previously. 
Ryan et al (l968t) used BAL and EDTA with rabbit plasma 
but studios described above show a lack of effect of
78
this combination in human and bovin© plasma. Hydrogen 
ion concentration again influenced the action of the 
EDTA-phenanthroline combination, particularly in cod, 
eel and human plasma. DP inhibited angiotensinase 
hydrolysis of angiotensin in eel plasma incubations 
at pH levels below 6. DP was therefore used in the 
measurement of renin-substrate in the eel (2.2.4.1.)
if C i v
id.
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1 & 7 d -  d  ir :?■ i d
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2,2,3* Measurement of Renal Renin
As discussed in section 2,1,, concentration of 
renin in extracts of kidney tissues may be 
sufficiently high for a direct bioassay* The 
feasibility of applying this to a wide variety of 
vertebrate species was briefly studied* For reasons 
discussed below, this approach was not satisfactory 
for the assay of eel renal renin and effort was 
therefore concentrated on developing an enzyme 
kinetic technique (see also section 2*1*2.1* 111)*
Factors affecting the reaction of eel renin with its 
substrate were studied in some detail and the results 
are described and discussed below*
2.2*3*1* Direct bioassay of renal renin 
I * Pressor responses to untreated extracts
Renal extracts from 39 vertebrate species (see 
Table 12) were prepared as described in section 2*2*1* 
and tested on at least two occasions each by intra­
venous injection into the rat* Where indicated, 
blood pressure responses were typical of these des­
cribed for mammalian renin, and examples are illus­
trated in figures 9& and 9b* However, in amphibia, 
fish, reptiles and to a lesser extent, birds, the 
response was of unusually short duration (Figs* 10,11,12).
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B.P
mm.Hg
5  min
9 0
7 0
5 0
Fig.9a. Blood pressure responses to mammalian renins. 
The kidney extracts are A « Rat (2 mg), B * Aardvark 
(20 mg), C = Porpoise (10 mg).
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Fig.9b. Blood pressure responses to mammalian renins. 
The kidney extracts are A = Rat (2 mg), B = Dog 
( (i) = 2 mg, (ii) » 20 mg), C * Polar Bear (2 mg),
D « Crab-eating Mongoose (2 mg), E = Binturong 
( (i) b  2 mg, (ii) * 20 mg).
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RAT
BP
mm.Hg
9 0
7 0
5 0
5 min
B C D F A
Fig.10. The vasopressive effects of fish and 
amphibian kidney extracts, compared to rat renin 
A b 2 mg kidney), B = Cod (40 mg), C = Sea trout 
40 mgV, D = Mackerel (20 mg), E = European Eel 
), F =40 mgJ Frog (20 mg).
5  min
B P
mm.Hg
t t 11 t t
B C D E F A
8 0
6 0
Fig.11. The vasopressive effect of reptile and 
amphibian kidney extracts, compared to rat renin
!A as 2 mg), B = Frog (20 mgj, C = Radiated tortoise 40 mg), D as Porters Giant Tortoise (40 mg), E = Russell's Viper (40 mg), F * Blue Spiny Lizard(40mg)
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5min
RAT
ap
mm.Hg
6 0
4 0
Fig.12. The vasopressive effects of avian kidney 
extracts, compared to rat renin (A = 2 mg), B = 
Serai-palmated Goose (40 mg), C = Rhea (20 mg), " 
D = African Crowned Crane (4o mg), E = Humboldts 
Penguin (40 mg), F » Peafowl (40 mg).
5 min
100
RAT 
ap
mmHg
60 -
1 1
A C
Fig.13. Response of rat blood pressure to i.v. 
injections of 7 mg cellophane diffused eel kidney 
extract (A), to 7 mg of same extract, non-diffused 
(b ) and to 0.9 mg of this non-diffused extract (c)
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One possible explanation for this was that the extract 
was contaminated with a short-acting pressor substance 
in addition to renin. The nature of this contamination 
was investigated using eel renal extracts.
II* A diffusible pressor substance in extracts of 
eel kidney
The effect on the rat blood pressure on intra­
venous injections of eel renal extracts before and 
after dialysis is shown in figure 13 clearly the short 
acting pressor substance was diffusible through
cellophane membranes (Visking tubing). Incubating
„ o
the extract at 80 for 30 minutes did not appreciably 
affect its pressor response (Fig 15)* Because, when 
applying the enzyme kinetic technique (as in 2.2.3*2*) 
eel renin was shown to be denatured by heat and did not 
diffuse through cellophane, it is unlikely that the quick 
acting response is attributable to renin. The possi­
bility that it was due to angiotensin was considered. 
Although angiotensin is diffusible and heat-stable 
it would be unlikely to survive in crude extracts of 
kidney with high angiotensinase content. Furthermore, 
comparison of the effects of eel renal extracts and 
angiotensin II on rat blood pressure (Fig 14) showed 
a different time—course of response.
1 0 0
RAT
ap
mm.Hg
60
84
5 min
11 11
A B C D
Fig.l4. Rat blood pressure response to angiotensin 
XI (A « 8 ng, C = 4 ng) and eel kidney extract 
(B a 7 mg, D » 3 mg).
RAT
ap
mm.Hg
80
60
5 min
•f
(ii)
B B A B A
Fig.15. Effect of high temperature on the vasopressive 
substance In non-diffused eel kidney extracts. A = 4*3 
mg of unheated extract, B (l), (XX), (ill) * 4.3 mg of 
extract heated at S0°C for 2, 10 and 30 minutes res­
pectively.
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Because adrenal tissue is present within the 
kidney of the eel it seems probable that catechola­
mines were largely responsible for the pressor 
effect of the extracts (see discussion 2.2.3.5»).
When these are removed by dialysis the amount of renin 
remaining was too small to be assayable by direct 
injection in the rat* A more sensitive enzyme 
kinetic method was developed for this reason*
2.2.3*2. Enzyme kinetic estimation 
of renal renin in the eel 
I* Conditions of incubation
(1) Diisopropyl phosphite . ...........  15 Jil
(2) pH 6*2 phosphate buffer........ to 450 jxl
(3) Ox substrate (see Methods 2.2.1)
4
dialysed to pH 6 . 2    * 2 ml
(4) Eel renin
(10$ dilution of original extract). .50 jil
The total volume of the mixture was 2*5 ml and
its pH lay between 5*6 and 5*7* The mixture was then
incubated at 37° for 4 hours. Aliquots were removed
at 2 and 4 hours and instantly frozen in a 1 dry ice'/
oacetone mixture before storing at -20 until bioassay.
II* Calibration curve
A calibration curve was made by incubating
86
'■* different quantities of standard eel kidney renin 
with a constant amount of substrate in the presence 
of DP. The relation between the velocity of angio­
tensin formation and the concentration of standard 
eel renin is shown in Figure 16. It was also 
necessary to show that the calibration curve obtained 
could be used to measure renin in other extracts of 
eel kidney tissue. This would not have been 
possible, if such extracts contained inhibitors 
or accelerators of the renin—substrate reaction in 
addition to renin. In such an event a serial 
dilution curve for the extract would not have been 
parallel with the standard renin preparation and use 
of the calibration curve to measure renin in the 
extract would have been invalid.
To test this possibility serial dilution curves 
were made from 4 extracts of different eel kidneys • 
As can be seen in Figure 16 these followed the same 
slope as the calibration curve with standard renin. 
Ill• Expression of results.
Renal renin concentration was derived from the
/
rate of angiotensin formation by reference to the 
calibration curve (Fig. 16). For the purpose of this 
study only, one unit of standard eel renin was
By
120
ANGIOTENSIN 
FORMATION 
n M /4 h  r
60
1*20*80 4O
UNITS of RENIN /m l. INCUBATION MIXTURE
Fig.l6. Calibration of eel renin concentration 
The quantity of* renin is expressed as unit s/mg of 
kidney tissue; 1 ml of inbucation mixture contains 
0*4 mg. A s  standard eel kidney renin pool (see 
materials section 2.2.1). X, +, ©, 0 = four indi­
vidual eel kidney extracts. ®  = Blank inoubation 
mixture (buffer replacing kidney extract).
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arbitrarily defined as the amount which produced 
angiotensin at a rate of 97 (lOO ng/ml) of in­
cubation mixture per 4 hours of incubation. The 
concentrations of renin in the extract are expressed 
as units per mg of tissue. Though similar in prin­
ciple, the unit of renin as defined here is not 
identical with that defined for man (Brown et al 1964)•
IV• Precision and reproducibility
Replicate assays of pooled eel renal extract were 
made over a period of 18 months. A result 0.85 units 
of renin/mg — 0.08 SD (n « 9 ) was obtained. This 
gives a coefficient of variation of 9*4$. Studies 
of the recovery of eel renin were not possible because 
no angiotensinase-free preparations were available. 
However, there was no significant deterioration in the 
eel renal preparation over the 18 months of study.
V. Suitability of bioassay standard
Table 8 shows the results of a comparison of 
angiotensins 1 and IX as standards for bioassay of 
eel renin—ox substrate incubation product using a 
pooled incubated material. There was no significant 
difference (p = 0.3 to 0.4) between the results ob­
tained using these two standards. As will be dis—
89
Table 8. Eel kidney renin method:
validation of bioassay standard
Angiotensin
standard
No. of 
Assays
Sample 
Mean yM
SD
jiM
SE Students
t
test
I (0.97j»M) 11 1.769 0.108 0.033
t=0.964 
p=0•4 to
0.3
II (0.97 pM 11 1.824 0.156 0.047
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cussed, this was not the case in the method used to 
measure renin-substrate in human plasma (2.2.4.1).
2.2.3.3. Factors affecting the eel
renin-ox substrate reaction
I. Hydrogen ion concentration
The yield of angiotensin after 4 hours of incu- 
obation at 37 was studied over a range of pH values. 
As can be seen from Figure 17 maximum yields were ob­
tained at pH 5*6 which was therefore assumed to be 
the optimum pH for this reaction under these con­
ditions. When- the time course of the reaction over 
the same range of pH levels was examined (see Fig.lS) 
some evidence of denaturation was revealed at a pH of 
6.6 or above. The phenomenon was studied in more 
detail (see Fig.19) using the following experimental
protocol.
•*
Kidney extracts were made as described above 
but in a range of phosphate buffer solutions 
(pH 4.6-8.5)* They were then dialysed against the 
appropriate buffer (using 3 changes, each of 5L) of 
the same pH for 24 hours. The pH was adjusted to 
5*6 and the different pH treated extracts incubated 
as before with substrate at pH 5*6. The results 
confirm the destruction of eel renal renin at pH
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>pH 5-6
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ANGIOTENSIN
nM ■•pH 4-7
•p H  6-2
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—•••pH 6-6 
   pH 7-2
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Fig.17• Effect of pH on eel renin-ox substrate 
reaction. The incubation was carried out at 37° • 
Each point represents the mean of duplicate assays.
4 0
ANGIOTENSIN
• n
nM
20
0 Li
6
pH Of INCUBATION
Fig.18. Optimal pH for the reaction of eel renin with 
ox substrate. This graph has been plotted from the 
data on fig.17* The angiotensin concentrations at 
i hour of incubation were used. Each point represents 
the mean of duplicated assays•
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levels in excess of 6,2 (Fig.19)*
II. Temperature
Incubations were carried out at a range of
temperatures varying from 4°-60°. The results are
illustrated in figure 20. Two conclusions may be
drawn from these data. Firstly, initial velocity
oincreases with temperature to a maximum at 50 ,
thereafter decreasing presumably due to thermal
denaturation of the enzyme. Secondly., over a
4-hour incubation the highest mean velocity, giving
the greatest total yield of angiotensin, occurred
at 37° although greater yields (0.38 could be
obtained over very long incubation periods (6 days)
oat the slightly lower temperature of 31 • It must
therefore be assumed that some thermal denaturation
occurs even at 37°• As will be described in section
2.2.4.2. thermal denaturation of eel renin-substrate
o
may also occur at temperatures less than 37 •
III. Time course of eel renin-ox substrate reaction
Over an extended period of time, the rate of an 
enzyme-catalysed reaction in vitro under constant 
conditions of pH, temperature etc., falls progress­
ively with time. This can be due to several factors
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Fig.19* The denaturation of eel renin at pH levels 
above 6*2. The eel renin has been incubated here with 
ox substrate at pH 5*7> after the kidney had been minced 
then diluted and subsequently cellophane-diffused over 
the following pH ranges A  at 4*6, X at 5*7> 0 at 6,2,
0 at 6.9^+ at 8*5* Each point represents the mean of 
duplicate assays*
100
37’
ANGIOTENSIN
nM , • 30*
50
>18'
---
HOURS INCUBATION
Fig*20, Effect of temperature on the reaction of 
eel renin with ox substrate. The incubation was 
carried out at pH 5*7* Each point represents the 
mean of duplicate assays*
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of which the most common are progressive denaturation 
of the enzyme, approach to and arrival, at a state of 
equilibrium for the reaction, depletion of substrate 
and release of inhibiting compounds during the 
redaction* For the purposes of estimating renin 
concentrations, it is important that the initial 
velocity is maintained for as long a time as possible 
and this can be ensured in most cases by using a 
large excess of substrate*
The time course of the eel renin-ox substrate 
reaction was therefore compared with that of human 
renal and human plasma renins with the same substrate* 
The rate of hydrolysis of ox renin substrate by 
different quantities of human renal renin is relative­
ly constant (Fig 21) over long periods (Brown et al, 
1964)* A similar situation exists with human renin 
extracted from plasma* Figures 22 and 23 however 
reveal that the hydrolysis of ox substrate by eel. 
renin does not proceed at a constant rate whether 
incubated at 20, 30 or 37°C* Nevertheless, the 
rate of angiotensin formation was sufficiently 
constant to produce an adequate calibration curve*
Four other reasons for inconstant velocity of 
angiotensin formation were considered*
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Figo21, Reaction of three different concentrations 
of human kidney renin (A =1 units/ml., B0=*5 units/ml 
C = *25 units/ml) with ox substrate at 37 C. Assay 
brackets are derived using the rat blood pressure 
preparation*
>30*
150
100
ANGIOTENSIN
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50
100.50
HOURS INCUBATION
Fig,22, Reaction of eel renin with ox substrate at 
20° and 30°C, Each point represents the mean of three 
assays.
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0-5
•  E
50250
h o u r s  in c u b a t io n
Fig.23. Reaction of* human (x) and eel (•) renins ' 
with ox substrate. For human renin (Brown et al 
1964), 1 « 1 human unit/ml; 2 * 0.2u/ml; 3 = 0.1 
u/ml, 4 = 0.02 u/ml. For eel renin, A = 0.92 eel 
units/ml; B = 0.69 u/ml; C « 0*46 u/ml; D = 0.23 
u/ml; E ** 0.092 u/ml. Each point represents the 
mean of duplicate assays.
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(i) Effectiveness of DP as an angiotensinase 
inhibitor
Recoveries of angiotensin II (485 nM) from eel 
ronin-ox substrate incubations in two experiments were 
80 and 100$ respectively. This strongly suggests 
that the falling rate of angiotensin formation is not 
due to angiotensinase activity#
(ii) Presence of pepsin
Unlike human and dog renin, eel renin is inac­
tivated at pH levels in excess of 6.2 (see above).
Fe? n shares this characteristic. Because pepsin 
produces, on incubation with plasma, a peptide 
indistinguishable chemically and pharmacologically 
from angiotensin (Croxatto and Croxatto 1942) the 
presence of pepsin in the eel renal extracts might 
result not only in a spuriously increased rate of 
angiotensin formation but also in the subsequent 
hydrolysis of the octapeptide. These phenomena * 
might account for the failure of the reaction to 
proceed at a constant rate.
Pepsin, but not renin, is inhibited by poly-L-ly- 
sine, (Lumbers and Skinner 1969)* The presence of 
pepsin was, therefore, tested by incubating eel renal 
extract and ox substrate in the presence of this 
inhibitor (0.5 mg/ml). The results illustrated in
98
Figure 24, show that poly-L-lysine did not affect 
the time course of the reaction. Contamination 
of tjie renal extracts by pepsin is not an important 
factor. Also pepsin would be expected to degrade 
the angiotensin (see Table l), but this did not 
occur.
(iii) Mixed nature of ox substrate preparation
Ox renin substrate preparations may contain 
several substrates (see Skeggs et al 1964) and these 
may vary in their affinity for eel renin. Thus, 
although an apparent excess of total substrate is 
used, only a small proportion may react with the 
enzyme and substrate concentration would then be 
limiting. To test this possibility the following 
observations were made.
The yield of angiotensin from the ox renin 
substrate preparation using eel and human renal 
extracts was compared ( Fig. 25). On prolonged in­
cubation, eel renin produced only about one fifth of the 
angiotensin released by human renal extract.
Moreover, when human extract was added to the eel 
renin incubation, after angiotensin concentration had 
reached a plateau, angiotensin release recommenced 
until the final concentration approximated
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Fig.2k. Effect of poly-L-lysine on the eel renin- 
ox substrate reaction. Incubation at 3 7 ° C  with (x) 
and without (d) poly-L-lysine were compared at two 
concentrations of eel renin (0.92 units/ml for upper 
aiid 0.23 units/ml for lower pair of curves.
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Fig.25. Reaction of high concentrations of eel and 
human renin with ox substrate. Curve A was produced 
by a high concentration (l u/ml) of human renin, 
curve B by the highest available concentration of eel 
renin (0.83 u/ml). At point C, when the eel kidney 
renin - ox substrate reaction was approaching a 
plateau, human renin (l u/ml), was added to an aliquot 
of tube B. Each set of tubes were run in duplicate.
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to that obtained with human extract alone. Thus, 
not all the substrate appears to be available to 
eel renin-catalysed hydrolysis.
This may not, however, be the explanation 
for the falling reaction rate. According to Dixon 
and Webb (1967), an enzyme catalysed reaction should 
proceed at a constant rate at least until 20% of the 
substrate is consumed. Since eel renin is capable 
of releasing 0.53 jiM of angiotensin from this sub­
strate, the reaction should proceed at a constant 
rate until a concentration 20% of this (i.e. 0.1l6|iM) 
is attained. However this is not the case.
Xt must therefore be concluded that a hetero­
genous substrate preparation is not the cause for 
the progressive fall in the rate of the reaction time.
(iv)Inhibitors
One type of renin inhibitor already studied by 
other workers is a phospholipid. Phospholipid 
inhibitors of the type described in section 2.1.1.9 
are destroyed by the action of phospholipases. Eel 
renal extract and ox substrate were incubated in 
the presence and absence of phospholipases C and D 
(0.1 mg/ml). The results indicated that neither 
phospholipase improved the yield of angiotensin.
101
Phospholipase D had no effect while C reduced the yield 
still further below the control. The reason for this 
decrease is not clear.
The inhibitor if any, is therefore probably not a 
phospholipid. The study was not pursued beyond this 
point so that other types of inhibitor cannot be 
excluded.
IV Enzyme kinetics.
As can be seen from Fig. 26, Lineweaver-Burke plots 
for human and eel kidney renin were linear with serial 
dilution of ox substrate.
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Fig. 26. Lin© we aver-Burk© plots of* eel (®) and human 
kidney (x) renin with serial dilution of* ox substrate 
Two concentrations of* each enzyme were studied and each 
point represents the mean of* duplicate assays V = nM 
angiotensin ll/hour and S = nM of* ox substrate.
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2.2.3*4. A Qualitative test for renin in 
extracts of kidney tissue.
Development of* a method for measuring renin in 
kidney tissue requires an extensive series of tests for 
each species studied. Because it was intended to 
test for the presence (rather than the quantity) 
of renin in the kidney of a large number of 
vertebrate species (section 4.2.I.), a simple 
qualitative test for renin was also developed.
Kidneys were obtained, processed and extracted as
described in section 2.2.I.2. The extracts were
tested for angiotensinase (see section 2.2.2.), and
oincubated at 37 with ox substrate and DP as 
described earlier in this section. Aliqupts of the 
incubation mixture were taken at 4 and 16 hours and 
angiotensin was determined by bioassay. The results 
are expressed in Table 12 as the amount of angiotensin 
formed after 16 hours incubation.
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2.2.3.5* Discussion
Direct Bioassay 
Direct bioassay of eel renal renin by intravenous 
injection into the rat was found to be of no 
practical value. Renal extracts were heavily 
contaminated with another pressor compound which was 
thermostable and which diffused through cellophane. 
Since the eel kidney contains chromaffin tissue, 
this substance is almost certainly catecholamine•
That this is so is suggested by the fact that the 
pressor effect of renal extracts in teleost fish 
can be obliterated by the <x? adrenergic blocking agent 
phenoxybenzamine hydrochloride (Mizogami, Oguri,
Sokabe and Nishimura 1968).
When this diffusible component had been 
removed, the residual pressor response, presumably 
due to renin, was too small to be measured reliably 
by direct assay. This could be due either to 
the lack of renin in the eel kidney or to a lack
i.
of sensitivity of the rat to renin from this species. 
The former possibility is not borne out by 
subsequent studies (see below) and a likely 
explanation may be that eel renin does not react with
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renin substrate circulating in the plasma of the 
test rat. These studies indicated the need for 
more sensitive methods.
XI. Enzyme-Kinetic method
The greater sensitivity of the enzyme-kinetic 
technique has been established in studies of 
mammalian renin (Lever et al 1964, Brown et al 
1964 a and b). The improvement to sensitivity is 
achieved by the greater quantity of angiotensin 
which is formed when renin is incubated in vitro 
with substrate over a prolonged period. As can 
be seen from the preceding experiments, when eel 
renal extracts and ox substrate' were incubated for 
long periods, the reaction rate decreased with 
time. The mechanism of this effect was not 
discovered. It was not due to thermal denatur­
ation; to reappearance of angiotensinase activity, 
or to pepsin. An insufficiency of renin substrate 
was also an unlikely explanation.
For practical purposes as indicated in Fig. 23 
the enzyme-kinetic assay was not compromised by 
the failure to maintain constant velocity of 
angiotensin formation over a prolonged period.
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The amount of* renin present in all extracts 
was sufficient to produce a measurable quantity 
of angiotensin. It was also shown that dilution of 
renin-containing extracts produced a decrease 
of velocity comparable with that resulting from 
dilution of standard renin (Fig 16). Renin present 
in the extract could, therefore, be referred to the 
renin content of the standard.
Ill• Detection of renin in extracts of kidney tissue
A simple method for detection of renin was tested 
in a wide variety of vertebrate kidney extracts.
The positive results usually found (see Table 12) 
indicates that renin is present in a particular extract. 
In these species there should be no difficulty in 
establishing quantitative methods along the lines 
described for eel renin (see above).
Negative results (angiotensin content less than 
19 nM at 16 hours) should be interpreted with 
caution. Failure to produce angiotensin could result 
from absence of renin in kidney tissue, from a 
failure to extract renin from kidney tissue, from 
inactivation of extracted renin or fromsfailure of 
the particular species of renin to react with
ox substrate. For these and other reasons, no 
conclusion can be drawn as to the amount of renin 
present In the kidney of a particular species.
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2*2*4, Measurement of plasma renin-substrate
The need for a properly validated technique 
for renin-substrate measurement in main has been 
mentioned (2 *1 *2 .2) and defects in techniques 
currently available for man will be discussed 
(2 .2.4.1).
Two methods only (Mizogami et al, 1968}
Nolly & Fasciolo, 1971 a & 1972) are available 
for substrate measurement in fish and these are 
based on the techniques used in man.
In this part of the thesis two new methods 
for plasma renin-substrate measurement are Mies— 
cribed: first a technique for man (2.2.4.1) and
then one for the eel (2.2.4.2). The method for 
man has been submitted for publication (Tree 1972) 
and the results obtained using the techniques have 
been reported (Weir et al 1970 a & b; Weir et al 
1971? Dusterdieck et al 1970; Love et al 1971; 
Brown et al 1971; Robertson et al 1971; Medina et 
al 1972).
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2.2.4.1. Measurement of plasma 
renin-substrate In man
As in other methods for measuring renin-substrate, 
the present technique is based on the conversion 
of substrate to angiotensin by sin excess quantity 
of renin, followed by assay of the angiotensin formed.
X, Materials and Methods
The methods of preparation of human kidney renin, 
human renin-substrate, angiotensin standards and 
phosphate—saline buffer solutions are to be found 
in section 2 .2.1 .
(i) Angiotensinase inhibitor solution (AIS).
This contained 1,56 mM phenanthroline and 16.8
raM disodium EDTA, and was prepared in pH 7*4 buffer
(8.6 mM NaH2PC>4 , 41.4 mMNa^QPO^, 81.6 mM NaCl) with
2g/l neomycin sulphate. Its total concentration
at 0.15 M made it isosmotic to human blood (see
ensuing method (ii) on sample collection). This. AXS
> owas stored at +4 C.
(ii) Preparation of the plasma sample 
Peripheral venous blood was taken in a plastic
syringe and 6.25 ml was transferred immediately to a 
25 ml volumetric flask containing 18.75 <ml of AIS. 
Packed cell volume was measured on the remainder using 
the microhaematocrit technique (Hawksley). Blood and
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AIS were throoughly mixed, centrifuged at 1400 g and the 
supernatant plasma-AIS mixture was removed and 
stored frozen at —20°C until assay*
(iii) Incubation and assay 
2 ml of the thawed plasma-AIS mixture was 
added to 0*5 ml of human renin solution* The 
mixture, which had a pH of 6.8 was incubated at 37° 
for 2k hours* Aliquots of the mixture were taken 
after 8 and 2k hours incubation and stored frozen 
until assayed using the anaesthetised rat blood 
pressure preparation (Peart 195$) a*kL angiotensin I 
(0.1 jiM in AIS) 'as the standard* The mid-point 
of each assay bracket was taken as its value and 
the mean of the 8 and 24-hour aliquots was used 
to calculate substrate concentration (see later)*
Where brackets for the two aliquots did not overlap, 
the sample was reincubated and reassayed and the 
result accepted only when the brackets overlapped*
Of 1075 samples so far tested, 1059 (9&$) were 
satisfactory on the first incubation and assay and 9 
of the 16 failures were acceptable on re-incubation.
The remaining 7 samples, less than one per cent of 
the total, were rejected*
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(iv) Calculation and expression of plasma
renin-substrate concentration.
Allowing for the dilution of blood with AIS, 
for the dilution of the plasma-AIS mixture with 
renin solution and for the molarity of the angio­
tensin standard, the substrate concentration of the 
original plasma samples was derived from the 
expression -
and B = the volume of red blood cells in the 6.25 ml 
blood sample.
Substrate concentration was expressed in 
molarity rather than as. a "concentration" equivalent 
to the standard angiotensin as in the other methods 
listed in Table Not only is molarity a more
precise means of expressing the concentration of a 
solute but it enables a comparison to be made of 
data obtained using different forms of angiotensin 
as a standard for the bioassay. The assumption
(6.25 - B)
Where A = the ratio
Angiotensin concentration 
in unknown
Angiotensin concentration 
of standard
TABLE 9
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Author
Present
Method
Skinner 19^7
Maebashi et 
al 1965
Gould and 
Green 1971
Pickens et 
al 1965
Rossett and 
Veyrat 1971
Helmer 1965
Ayers 19^7
Imai and 
Sokabe 1968
Mean values of 
subjects. For 
present method 
calculated and
Mean of normal
range Standard
jiM used
Plasma
or
serum
1.01 (young 
men) 
0.85 (young 
women)
1.07
O .87
O.76 (young 
men) 
0.’70 (young 
women) 
0.92 (older 
women)
0.70
0.57 (young 
men)
0.41
Angiotensin
I
Angiotensin
II
Probably
Angiotensin
II
Angiotensin
II
Plasma
Angiotensin
II
Angiotensin
II
Probably 
' Angiotensin 
II
Plasma
Plasma
Serum
Plasma
Plasma
Plasma
0.33 Probably
Angiotensin
II
Plasma
0.29 Probably
Angiotensin
II
Plasma
plasma renin-substrate in normal 
the purpose of comparison with the 
, substrate values have been re­
expressed in terms of molarity.
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Implicit in ali method for measuring renin-substrate 
is that 1 Mole of substrate is converted by excess 
renin in the absence of angiotensinase to 1 Mole of 
angiotensin.
(v) Characterisation of the angiotensin formed 
during incubation.
The pressor material produced by incubation of 
renin and substrate in the presence of angiotensin­
ase inhibitor solution was characterised in three 
ways s
(a) By radioimmunoassay for angiotensin I using 
an antiserum with a 0 .016/o cross-reaction against 
isoleucine 5 angiotensin IX (Waite 1972).
j(b) By radioimmunoassay for angiotensin II using
i '
an ahtiserum with a 0 .6^ cross-reaction against.
dsoleucyl-5 angiotensin :I (Dusterdieck and MoElWee
* l f
;i97i> ;
j(c) By chromatography .on a CM—Sephadex (Pharmacia)
column capable of separating completely angiotensin I
1 !
ifrora angiotensin II and with•comparable recovery for
! ’ i "•
(the two peptides (Leckie et al 1972).
i .
jll. Results .
Assay of renin-substrate requires that the 
substrate is converted completely to angiotensin by
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renin, that the angiotensin formed is not subsequently 
destroyed and that it is measured by comparison 
with a valid standard,
(i) Nature of the angiotensin formed
Using antisera with negligible cross-reactivity 
(see materials and methods), radioimmunoassay of 
the incubation product indicated that most if not 
all of the pressor material was in the form of 
angiotensin I (Table 10), Similarly, chromato­
graphy of the material on a system capable of 
separating the two forms of angiotensin showed that 
a high proportion of the starting material eluted 
a s  angiotensin I with little activity detectable 
in fractions which would contain angiotensin IX 
(Table 10).
(ii) Comparison of angiotensin I and 
angiotensin II as standards.
Val-5 angiotensin II is often used as a standard 
for the assay of renin-substrate (Table 9)*
Because the assayed material - in the present 
experiments at least - was known to be angiotensin I 
and not angiotensin II, the two peptides were compared 
as standards. Six comparisons were made using 
bioassay.
115
Table 10.
Bioassay of Radioimmunoassay, nM
A original
material,nM For Angiotensin I For Angiotensin II
62 65 1.0
153 154 2.2
61 72 5.0
105 112 2.1
101 154 5.0
• CM-Sephadex Chromatography
B Angiotensin I 
Recovery (%)
Angiotensin II 
Recovery (%)
150 80 <6.7
185 67 <5.^*
A. Comparison of bioassay and radioimmunoassay measure­
ments of 5 samples of incubation product,
B. CM-Sephadex chromatography of two samples of incubation 
product. Recoveries of synthetic angiotensin I and 
angiotensin II are in the range 64-93%
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(a) Angiotensin I (0.08 jjM) against angiotensin 
II (0.1 jiM).
(b) The incubation product (angiotensin i) against 
angiotensin II (0.1
(c) Incubation product against angiotensin I 
(0.08 jiM).
(d) Angiotensin I (0.08 jiM) against angiotensin I 
(0.1 jiM).
(e) Angiotensin II (0»08 jtiM) labelled "angiotensin 
I" (as a means of avoiding observer bias) against 
angiotensin II (O.l^iM).
(f) Angiotensin II (0.08 jjM) against angiotensin 
II (0.1 jiM) .
Twenty six assays were made in each experiment.
In 13 (indicated as group 1 in Fig. 27) » the test rat had 
been anaesthetised for less than 2 hours and in 13 
(indicated as group 2), for longer than this.
The results of the first three comparisons *(a,b 
&c) are shown in Figure 27. In rats which had been 
anaesthetised for more than 2 hours, angiotensin II 
produced a falsely low value when used as a standard 
to assay both angiotensin I (Figure 27A) and the 
incubation product (Figure 27B). N o  such discrepancy 
was apparent when angiotensin I was used as standard
COMPARISON of ANGIOTENSIN STANDARDS
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Group I  Group j[
A. ASSAY of ANGIOTENSIN J 0 08mM 
0-0 9-i
ANGIOTENSIN IT 
pM
006-
0-03-
B. ASSAY of INCUBATION PRODUCT
0*09-,
ANGIOTENSIN I
pM 0-06-
0*03-1
C. ASSAY of INCUBATION PRODUCT 
0*09-,
ANGIOTENSIN J 
PM
0-06 J
«v*
••••
Fig.27♦ Comparison of* assay results in two groups of* 
rats:-
Group I. Those in use for less than 2 hours 
Group II.Those in use for more than 2 hours.
See text for details of experiment.
In experiments a and b, the difference between 
groups I and II were significant (paired t = 5*^8, 
p <0.001 and paired t * 3*^7* p <0.01 respectively). 
There were no significant differences between groups 
I and II in experiment c (paired t = 1.15» p> 0.2). 
The horizontal bar denotes the mean.
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7( 27 C). Nor were significant (p^O.l by 
Student*a t test) differences found in the three 
control experiments (d# e & f) in which the 
individual peptides were tested against a dilution 
of the same peptide. Xt is also noticeable in 
Figure 27 that the scatter of results was greatest 
when angiotensin XX was used as a standard and that 
the initial value of the incubation product was 
higher with angiotensin X as a standard than with 
angiotensin II (t ** 3*0, p<^0.0l).
Angiotensin X was adopted as a standard for 
these reasons.
(iii) Inhibition of angiotensinase
A  mixture of phenanthroline and EDTA was chosen 
for the angiotensinase inhibitor solution because 
preliminary experiments showed that a combination 
of the two provided more complete inhibition than 
either tested alone (Fig. 5)* The ability of the AXS 
solution to inhibit angiotensinase in plasma 
was demonstrated by 10 assays in which mean recovery 
of angiotensin X (0.08 jiM) incubated for 1$ hours 
with plasma-AIS mixture was 103$ - 3«8 SD. In a 
further 10 assays in which angiotensin XI (0.1 u^M) 
was incubated for 18 hours with plasma, mean
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recovery was 105$ — 5*3 SD.
Recovery of angiotensin X (0.1 jaM) incubated with 
human renin (2 units/ml) £n AIS for 48 hours was 
84 and 67$ in two experiments.
Further evidence that angiote.nsinase was 
inhibited during the incubation of plasma, renin 
and AIS was provided by the plateau of angiotensin 
maintained during prolonged incubation (see sections 
iv and ix)•
(iv•) Completeness of the renin-substrate 
hydrolysis .
Accurate estimation of substrate depends upon 
its complete conversion to angiotensin. In the 
absence of angiotensinase, this would be indicated 
by the attainment of a plateau of angiotensin 
concentration during prolonged incubation 
(Fig 28). For the concentration of renin used 
(2”units/ml) the plateau was reached before 8 hours 
incubation whether the initial substrate 
concentration was high or low (Fig. 28). Aliquots 
for bioassay were, therefore, routinely taken from
the incubating mixture at 8 and 24 hours• The
/
similarity of mean angiotensin values in aliquots 
taken at these times for replicate estimates from a
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FORMATION of ANGIOTENSIN during INCUBATION
A N G IO T E N S IN
C O N TE N T(mM)
1*0 -i
04-
0 1 -
004-
001
12
“I
24
HOURS of INCUBATION
Fig.28. Changes of angiotensin content in nine plasma- 
AXS mixtures during the course of* incubation are shown 
as solid dots* Triangles represent the mean values at 
8 and 24 hours incubation in 43 replicate samples of 
stock plasma. Crosses represent mean values for 46 
replicate estimates from the dilute stock plasma. 
Further details of this experiment are summarised in 
Fig.30.
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plasma pool (see Fig. 30 and section (x)) also 
suggested that substrate hydrolysis was complete.
As a further test of complete hydrolysis, an 
increased concentration of renin (19.5 units/ml) 
was used for the incubation in 7 experiments. As 
compared with duplicate incubations using the 
standard concentration of renin (2 units/ml), the 
yield of angiotensin was slightly but insignificantly
( p ^ 0 .05) lower.
(v) Effect of diluting a plasma sample
As a test of the method, 4 plasma samples were
assayed in serial dilution. Predicted and measured
values agreed well (Fig. 29). Not included in the
1 oregression, but falling on the 45 slope was the mean 
value for 49 estimates of the dilute plasma pool 
(see section (x)).
These findings also suggest that inhibitors or 
accelerators of the renin-renin-substrate reaction 
are not influencing the concentration of angiotensin 
formed since serial dilution of such agents with 
substrate would have led to a discrepancy between 
measured and expected substrate values.
Agreement between these values also indicates that 
the plateau of angiotensin concentration represents
1 22
EFFECT of DILUTION on REN IN-SUBSTRATE
RENIN SUBSTRATE 
% HIGHEST VALUE 
lOO-i
60-
20-
20 60
% DILUTION
Fig.29. Effect of diluting plasma samples on sub­
strate concentration. Each symbol represents a 
different sample. Crosses represent replicate 
estimates of substrate from the undiluted plasma- 
AIS pool (47 estimates) and from a ten-fold dilution 
of this pool (49 estimates). The solid line rep­
resents a 45° slope, the dotted line the regression 
for data excluding the two orosses.
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complete or near complete hydrolysis of substrate 
rather than a balanced equilibrium state*
( vi) Recovery of added substrate
In 9 experiments, 6*25 ml of the stock solution 
of human substrate (0.62 jiM) was added to 6*25 ml of 
blood together with 12*5 ml of inhibitor solution 
(with concentration of EDTA and phenanthroline 
increased by 33% to allow for dilution by added 
substrate). As a control, 6.25 ml of the same blood 
sample was added to 18.75 ml of AIS in the usual 
way. The 9 pairs of samples were processed and 
assayed as described earlier. Mean recovery of 
added substrate, calculated from the differences 
between experimental and control values, was 94% —
32 SD. The large value of standard deviation is 
attributable partly to the combined variation of the 
two estimates of substrate used in the calculation 
of recovery (plasma samples with and without added 
substrate) and partly to the relatively small 
quantity of added substrate.
(vii) Effect of angiotensinase inhibitors 
on the renin—substrate reaction.
Because the angiotensinase inhibitors might 
interfere with the renin-substrate reaction and thus
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with the assay of substrate, aliquots of angiotensin- 
ase-free substrate (see methods) were incubated with 
renin in the presence and in the absence of 
inhibitor solution. No marked difference was found 
(0.12,0.13 and 0.13 of substrate in samples >vith 
AXS and 0,12, 0.12 and 0.11 uM in samples without AXS)
(viii) Effect of delay in transfer of blood 
to inhibitor .
To test the possibility that substrate loss might 
occur prior to the addition of inhibitor (by formation 
of angiotensin and its destruction by peptidases), 
the effect of delay in the addition of AXS to a blood 
sample with high renin content (l,040 units/litre) 
was studied. All of the following results 
represent the mean of duplicates. When aliquots of 
the blood samples were kept at +3°C for 5 and 24 hours 
before the addition of inhibitor, substrate 
concentration was —5% and +4% different respectively 
from that in aliquots to which inhibitor had been 
added without delay. When aliquots were kept at 
20°C for 5 and 24 hours the respective differences
were —9% and —26%. With AXS added to blood at the
i ooutset, but with a delay of 5 or 24 hours at 20 C
before centrifugation, substrate values differed
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from the original by -8# and ~-5$ respectively.
The practical implication of this study is that 
whole blood can be left for 5 hours at +20°C and for 
2k hours at +3°C before addition of inhibitor 
without affecting the result materially#
(ix) Effect of storage at -20°C
(a) Plasma-AIS mixtures were prepared from six 
normal subjects# Each mixture was divided into 
eight aliquots; one pair of aliquots was assayed 
directly and the remainder were frozen for 
varying periods, thawed and assayed# Mean substrate 
concentration in samples which had not been 
frozen (0.93 - 0.88 SEM) did not differ
significantly (p^ 0#2 in all instances) from 
samples thawed at 30 minutes (0#86 u^M - O.Ol),
63 days (l#09 ^ 0.08) and 305 days (l#03 M i
0 .06).
(b) Xn another experiment a large pool of plasma 
was obtained from pregnant women and a plasma—AXS 
mixture was prepared# A l/lO dilution of the plasma— 
AXS mixture was also made. Multiple aliquots of
the original and diluted mixtures were stored frozen. 
Two aliquots of each type were tested with every
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batch of* substrate samples. The results,
Illustrated in figure 30, show no tendency for 
substrate to deteriorate during the 17-month period 
of storage,
A new batch of renin was introduced at the 
point indicated in figure 30, No systematic change 
in substrate value resulted,
(x) Variation of replicate estimates 
Forty blood samples were taken in rapid
succession from a normal male subject. Assayed in 
two batches of 20 samples, these had coefficients 
of variations of 8.4 and 10,7$ respectively.
Data from the prolonged storage experiment 
(Fig, 30) were also assessed in this way. Within— 
batch replicates had a coefficient of variation of 
7.6# and between-batch replicates a value of 15*7$*
(xi) Normal and pathological values of renin- 
substrate.
Substrate concentration was measured in samples 
of peripheral venous plasma taken from normal 
subjects without previous restriction of either diet 
or physical activity. The values obtained from 19 
males aged 23-41 varied from 0,68 to 1,35 (mean
1.01 - 0.21 SD), Values for 30 females (not taking
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Fig. 30. Replicate measurement of* renin substrate 
concentration in samples frozen for different 
periods• Circles represent values for the undil­
uted material. Triangles represent a ten-fold 
dilution of this pool. A new batoh of renin was 
introduced at the point indicated by the vertical 
arrow.
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oral contraceptives and aged 19-34) varied from 0.45 
to 1.28 jiM. (mean 0.85 — 0.22 SD). Although this 
difference between the sexes was significant (t = 
2.53, p^0.02), the females were on average younger 
than the males and this could have contributed to 
the differences (see discussion III, below). Taken 
together, values for males and females had a mean 
of 0.91 uM (SD 0.23).
Applying the technique to physiological and 
pathological states, abnormally high values of 
renin-substrate have been found in normal pregnancy 
(0.84 - 7*48 >1, mean 3*07, n = 83 , Weir et al 1970a)
in women taking oral contraceptives (l.53 to 
6.13 jfiMf mean 3*03, n = 12, Weir, Tree, Fraser,
Chinn, Davies, Dusterdieck, Robertson, Horne and 
Mallinson, 1970b), in a patient with advanced renal 
failure and hypertension (Brown et al 1971s) and in 
anorexia nervosq (Love, Brown, Fraser, Lever, 
Robertson, Timbury, Thomson and Tree 197l).
Abnormally low values (less than 0.1 and 0.08 
have been found in 2 children with an unexplained 
form of hypokalaemia (Desinit, Cost, Brown, Fraser, 
Lever and Robertson 1970), in the nephrotic syndrome
uM)
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(0.36 and 0.43 yiM) and in untreated Addison's disease 
(0.40, O .36 and 0.16 jaM).
XXI• Discussion
When average values of substrate concentration 
in normal man are compared, wide variation is 
apparent amongst the methods currently in use 
(Table 9)* There are several possible explanations 
for this. Renin-substrate concentration could be 
falsely low because angiotensin II rather than 
angiotensin I was used as a standard, because a 
maximum concentration of angiotensin had not been 
achieved in the incubation mixture at the time 
of sampling, because recovery of substrate was 
incomplete, or because peptidases had destroyed 
angiotensin formed during the incubation. Tests 
described in this paper have shown that for the 
present method at least, none of these factors
made an important contribution to the results -
<
obtained.
Most of the techniques listed in Table 9 use 
angiotensin II as standard. The study described 
in figure 27 suggests that this could lead to 
inaccuracy if the peptide produced by incubation was 
angiotensin I. The product of incubation has not
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been identified in other techniques, though it is 
likely to be angiotensin I in those using EDTA as 
inhibitor (Skeggs et al 1956} Ryan, McKenzie and 
Lee 196Sm Hollemans, Van Der Meer and Kloosterziel, 
1969)• The practical implications of this is 
either that the product of incubation should be 
identified and the appropriate standard used, or that 
both standards (angiotensin 1 and angiotensin II) 
should be tested and validated.
Previous work has shown that equimolar amounts 
of angiotensin I and angiotensin II produced 
comparable effects oh blood pressure (Skeggs et al 
1956; Brown et al 1964s), The present study may 
not be in disagreement with this since rats were 
injected with phenanthroline and EDTA in the present 
experiments but not in the earlier studies.
Failure to reach a plateau of angiotensin 
concentration during incubation is a further 
potential source of falsely low results. Samples 
for assay could either be taken too early before 
the plateau had been reached, or, in the presence 
of angiotensinase, too late during the period when 
angiotensin concentration was declining (see Lever, 
Robertson and Tree 1964). Few of the methods listed
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in Table 9 routinely establish, that a stable plateau 
of angiotensin concentration has been reached*
Recovery experiments with added substrate are 
also important* Substrate may be lost during the 
preparation of samples for assay. Thermal 
denaturation occurs when some species of substrate 
are incubated at 37° (2.2*4*2.)• Also, inhibitors 
used in the assay could prevent complete 
conversion of substrate to angiotensin. None of 
the other methods listed in Table 1 reports 
recovery data. Although the recovery is said to 
be unaffected in the method of Skinner (1967)* no 
details are given of the technique employed to 
measure recovery or the range of variation.
AngioLensinase was effectively inhibited in 
the present technique and in most of those listed 
in Table 1. It is not clear whether this was 
achieved in the method of Ayers (19^7) and that the 
low value obtained for the normal mean by this 
method may be attributable to contamination with 
angiotensinase*
The experiments described earlier suggest that 
the speed with which blood is added to inhibitor 
solution is not critical. It may, therefore, be
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possible to simplify the method by centrifugation 
i oof blood at 4 C immediately after collection with 
storage of frozen plasma to await assay in angio— 
tensinase—inhibitor solution. Also, the results 
illustrated in table 10 raise the possibility that 
the angiotensin X formed by incubation could be 
measured by radioimmunoassay.
The relatively consistent results for 
replicates estimated over a 17-month period (Fig 30) 
indicates that the frozen plasma-AXS mixture is 
stable and that incubation and assay have not 
undergone systematic, change. Xt is also useful 
to have a monitoring system of this type when 
introducing a new batch of renin (Fig. 30) and to 
detect major deviation of results in a single batch.
The reservations so far discussed apply to the 
absolute values obtained by different substrate 
methods in man. There is less disagreement on the 
changes of substrate in physiological and 
pathological states. Where measurements have been 
made in man, all agree that plasma substrate 
increases during normal pregnancy (Helmer and Judson 
1963> 1967j Skinner et al 1972; Weir et al 1970a) 
in women taking oral contraceptives (Helmer and Judson
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1967J Skinner et al 1969; Weir et al 1970b) and 
in a proportion of patients with renal hypertension 
(Helmer 1964; 1965; Gould, Skeggs and Kahn 1966; 
Brown et al 1971s) • Lower than normal values have 
been observed in patients with hepatic cirrhosis 
(Gould et al 1966; Ayers 1967) and the nephrotic 
syndrome (Aida, Maebashi, Yoshinaga, Ichinohe 1965).
4  ii'-ijy C J ^ v t - s  ; ' -
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2,2.4.2* Plasma renin-substrate 
measurement In the eel
!• Introduction.
The technical problems likely to be involved in 
the development of a method for measuring renin- 
substrate in any species have been considered in 
the previous section. The problems encountered with 
the method for the eel were different from those in 
mans preparation of an angiotensinase-free standard 
renin proved more difficult, whereas the comparison 
of angiotensin I and angiotensin II as standard 
revealed none of the discrepancies apparent in man.
II. Materials and Methods.
The methods of preparation of buffer solutions, 
angiotensin standards, kidney extracts and also the 
procedures for eel exsanguination and denaturation of 
ichthyotoxin are to be found in section 2 .2 .1 .
III. Results.
(i) Inhibition of renal angiotensinase
(a) Preliminary studies with eel kidney extracts
Use of homologous renin is preferable in renin- 
substrate assay since not all species react with all
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species of substrate (Section 2.I.I.4.).
In 4 experiments 0.25 ml of eel plasma was 
incubated in the presence of 36 mM DP with 1.1 mg 
of eel kidney tissue/ml in a total volume of 5 ml, 
at pH 5*5 and a temperature of 20°C. Because a 
plateau of angiotensin concentration was not reached 
after 22 hours incubation an increased concentration 
of eel kidney extract was tested (4.3 mg/ml of 
incubation mixture). Although the initial 
velocity of angiotensin formation increased as 
a result angiotensinase activity was detected. 
However, DP concentration could not be further 
increased without affecting the assay rat (page73)
An alternative source of fish-kidney renin was 
therefore sought for the substrate assay.
(b) Preparation and use of sea trout renin in 
assay of renin-substrate.
Renin was extracted from kidneys of the sea 
trout as described earlier (page §2) . Again,
36 mM DP proved capable of inhibiting angiotensin- 
ase (Table 12).
In 7 experiments, when sea trout kidney 
extract (2.0 rag/ml of incubation mixture) was
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Incubated with 0.25 ml of eel plasma in the presence 
of 36 mM DP, a plateau of angiotensin concentration 
was reached* in 8 hours and maintained thereafter 
for a further 37 hours with only minor decline 
(Fig. 31).
(ii) Inhibition of plasma angiotensinase
As illustrated in figure 8, adequate inhibition 
of eel plasma angiotensinase was achieved by DP 
at 37°C, over the pH range 4.7 to 5*7* Similar 
results were obtained at the incubation 
temperature of 20°C at pH 5*4, 100$ of angiotensin 
X and 100$ angiotensin XX being recovered after 
18 hours of incubation.
(iii) Optimum pH .
Accurate measurement of optimum pH for the eel 
renin — eel renin-substrate reaction was not possible 
because above a pH of 6 , DP (36 mM) did not 
inhibit the angiotensinase present in the incubation 
mixture. Data from the experiment illustrated 
in figure 32 showed that the greatest velocity of 
angiotensin formation in these circumstances, 
occurred at approximately 5*4. This pH was 
chosen for the routine substrate assay.
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Fig.31. Reaction of sea trout renin with seven 
different samples of eel plasma. Mean value is 
shown as X.
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Fig. 32# Effect of* pH on the reaction between eel 
renin and eel substrate at 20°C. As Indicated in 
fig# 8 the decline of velocity at pH above 5*5 is 
likely to be attributable to angiotensinase•
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Fig.33. Effect of temperature on the reaction between 
eel renin and eel substrate at pH 5*^* Each point 
represents the mean of duplicate assays#
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(iv) Optimal temperature
Maximum formation of angiotensin occurred at a 
temperature of 20°C. Although the initial velocity 
of angiotensin formation was greater at 
temperatures higher than this, loss of activity 
occurred during the process of incubation (Fig 33)* 
Indirect evidence suggests that this loss occurred 
as a result of thermal denaturation of substrate 
rather than of the enzyme since the eel kidney 
enzyme incubated at 37°C with ox substrate formed 
angiotensin in a linear manner over a prolonged 
period (Fig 20).
A temperature of 20°C was chosen for the 
routine assay of the eel plasma renin-substrate*
(v) Technique used to measure plasma 
renin-substrate concentration in 
the eel«
The technique was based on observations 
described in previous sections*
(a) Heparinised samples of eel plasma were obtained 
andr stored as described on page 53; .
(b) 0.03 ml of a solution of DP was made up to
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4.7 ml with pH 6.2 buffer* 0.05 ml of sea-trout 
kidney extract (2 mg per ml of incubation mixture) 
was added.
(c) To this, 0.25 ml of eel plasma was added and 
the mixture (pH 5*5) was incubated at 20°C.
Aliquots were taken routinely at 8 and 18 hours 
and stored frozen to await bioassay.
(d) Prior to assay the thawed aliquots were 
placed in boiling water for 5 minutes to 
inactivate ichthyotoxin. The temperature in the 
incubating tube rose to 98°C during this 
process and prolonged incubation in boiling'water
for 30 minutes did not affect angiotensin concentration 
as compared with some samples which had been 
incubated for 5 minutes.
(e) The rat blood pressure preparation was used 
as before (page 5 4) for assay of angiotensin formed 
during incubation (Fig 3*0 and angiotensin XI,
97*2 nM (lOO ng/ml) was used as standard.
5 min
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Fig,34. Bioaasay of angiotensin from the reaction 
of sea trout renin upon eel plasma. B = 0,1 ml of 
incubation product and A = angiotensin II standard 
(ngs).
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Fig.35. Effect of dilution of an eel plasma substrate 
sample. The continuous line represents a 45° slope.
142
(f) Substrate concentration was expressed as in 
the method for man (page 113 )*
(vi) Validation of the standards
The product from the incubation of sea trout 
renin with eel plasma was assayed on nine occasions 
using both angiotensin I and also angiotensin XX 
as standards. There was no significant difference 
in concentration between the assays when these two 
angiotensins were used (Table ll).
(vii) Effect on substrate concentration 
of diluting plasma
As a test of the method and also of the 
completeness of substrate hydrolysis, serial dilutions 
of eel plasma were incubated in duplicate with 
constant amounts of renin and inhibitor. As in the 
method fdr man (Fig. 29)» the relation between 
dilution and measured substrate concentration did 
not quite follow the expected 45° slope (Fig. 35) 
because there was some loss of angiotensin at 
higher plasma concentrations, as the result of 
angiotensinase activity.
(viii) Results in normal eels
Plasma samples from 18 eels adapted to fresh
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Table 11. Eel plasma renin-substrate method: 
validation of bioassay standard.
Angiotensin
standard
No.
Assays
Sample 
Mean yM
SD
jiM.
SE
yM
Students
t
test
I (0.97^M) 9 1.002 0.056 0.019
t=l•597
p=0.1 to 
0.2
'
II (0.97jM) 9 0.946 0.088 0.029
water or seawater, (see section 4.2.2.) had a mean 
renin-substrate concentration of 0*9® -* 0,29 SD,
a result similar to that obtained in man.
(ix) Replicate variation
Six replicate assays of renin-substrate 
concentration from aliquots of a frozen plasma pool 
tested at intervals over the course of 7 months 
had a coefficient variation of 7$ with a mean 
substrate value of 0*95 pH*
145
2.2,5* Preparation and use of renin-substrate from 
the nephrectomised ox.
2.2.5*1* Preparation of substrate 
Six stirks weighing between 760 and 950 lbs. were 
subjected to bilateral nephrectomy as described 
on page 54 • One week after the operation they were 
anaesthetised with thiopentone sodium, maintained 
with halothane (Watts and Campbell 197l)» and then 
35 units.of heparin/lb. of body weight was injected 
intravenously. A glass cannula with a minimum 
internal diameter of 3*5 nun. was inserted into the 
left carotid artery and the animals were bled via 
polyethylene tubing into polyethylene containers.
The bleeding lasted for approximately ten minutes 
and this resulted in the death of the animal.
The plasma was separated by centrifugation at 
10° and 1,500 g. for 45 minutes. The 6 to 11 litre 
batches of plasma obtained from the six animals were 
dialysed separately at 4°C in 36/32 visking membrane 
against 25 litres of pH 5.7 buffer changed half-daily 
for 5 days. The composition of this buffer was as 
followss-
Na H2 P0^ - 44 mM
Na2H PO^ - 6.3 mM
NaCl 100 mM 146
Disodium EDTA 2.7 mM
Neomycin sulphate 0.02 g°jo
The small quantity of precipitate formed during 
dialysis was removed by filtration (Whatman 54) and 
further neomycin was added to make a final 
concentration of 0.2 g$>. The dialysed plasma was 
frozen and the small precipitate which formed on 
subsequent thawing was removed by centrifugation.
2.2.5*2. Properties of substrate
The six batches of plasma were tested separately 
for their properties as a standard substrate 
preparation.
I. Angiotensinase activity
Was assessed by incubation of 4 ml of substrate 
with 1 ml of Aspn I. Val 5* Angiotensin IX (97nM) 
for 48 hours. Recovery of angiotensin, tested in 
triplicate for each batch, varied from 90 to 110$.
II. Blanks.
Incubated alone, each batch of dialysed plasma 
formed no detectable angiotensin (less than 9#7 nM) 
when incubated in triplicate for 48 hours at 37 C. 
Aliquots of the incubating material were tested at 0, 
24 and 48 hours•
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III• Substrate concentration
Was assessed as described earlier (2.2.4.1.) by 
incubating with an excess of human renin. Measured 
in triplicate, the substrate concentration of the 
stirks, numbered one to six was 0.98* 1.22, 0.46,
1.51» 1*31 and 0.90 jjM, respectively.
IV. Rate of angiotensin formation during 
incubation with renin.
The individual batches of substrate were incubated 
with renin (0.005 u/ml) and angiotensin was produced 
within the assayable range of 20 to 115 nM at a linear 
velocity over 48 hours.
As a result of these tests dialysed plasma from 
the first and second stirks (but not the third because 
of its low concentration of substrate) was bulked 
(pooled ox substrate i) and subsequently that of stirks 
4,5 and 6 (pooled ox substrate II)• These pooled 
substrates had properties similar to those obtained 
with the individual specimens. They were stored at 
-20°C in aliquots.
V. The effect of bilateral nephrectomy
The value of bilateral nephrectomy in raising 
the plasma level of renin-substrate was shown in 
two stirks (numbers 5 and 6) by serial measurement of
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Fig.36. Effect of nephrectomy on renin-substrate 
concentration in the plasma of two stirks (numbers 
5 » X and 6 = 0 ) .
RENIN UNITS/t. 
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SUBSTRATE I
IOO
10
0 to tOOOO
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Fig.37. Duplicate assays of human plasma renin (units/ 
L, see Brown et al 1964) using ox substrate prepared 
by the method of Lever et al (1964) (substrate I) and 
also substrate prepared as described hereQ(substrate 
XX). The continuous line represents a 45 slope.
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substrate at intervals before and after the operation. 
Renin substrate concentration increased three—fold 
in one animal and four-fold in the other (Fig. 36).
VI• An unsuccessful attempt to increase substrate 
concentration by Stilboestrol.
Since the administration of oestrogen has been 
shown to increase plasma renin substrate concentration 
in the rat (Helmer and Griffith 1932) and in man 
(see page 128 ), it was hoped that an increased yield 
of renin-substrate could be obtained in the ox using 
Stilboestrol. In one ox, therefore, Stilboestrol 
diphosphate was administered intravenously in the 
following regime*- 2.5 nig. ddily for eight days; 
followed by 10 mg. daily for seven days; then 100 mg 
daily for thirty nine days and finally 1000 mg daily 
for fourteen days. Despite these very large doses, 
which on a weight basis are in excess of the oestrogen 
dose which has been shown to have an effect in man and the 
rat, the circulating level of renin substrate remained 
within the range 0.24 to 0*36 jiM throughout.
2.2.5.3. Use of ox renin-substrate 
The original intention was to use the new 
substrate for measurement of small quantities of renin 
in fish, amphibia, birds and mammals. The new
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substrate proved both easier to prepare and superior
v
in quality when compared with the previously 
used substrate from the un-nephrectomised ox (Lever 
et al 1964)• Tor these reasons the new substrate 
was substituted for the old in the routine methods 
for measuring human renin in the plasma of man 
(Brown et al 1964 a), the rabbit (Lever et al 1964), 
and the dog (Brown et al 1964b)* The change from the 
old to the new substrate was monitored by a comparison 
of duplicate measurements such as those shown in 
figure 37*
r..‘' — i>■ ■ ■ * .  ■ i. 4. j- * - - i ^  i
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2.3* General discussion of methods
Four new techniques have been described: 
methods for measuring renal renin in the eel and 
many other vertebrates (2.2.3 and 4.2.1.), methods 
for measuring renin-substrate in the plasma of man 
(2.2.4.1.) and fish (2*2.4.2.) and a technique for 
producing substrate on a scale sufficient for use 
in routine assays of renin (2.2.5*)*
Inhibition of angiotensinase, a central problem 
in the development of these techniques, has been 
described and discussed in a separate section (2.2.2) 
A large number of possible inhibitors was tested; 
most were not sufficiently effective, or were lethal 
to the assay rat. Although a universally 
effective inhibitor was not found, different 
inhibitors, or combinations of inhibitors, allowed 
quantitative recovery of angiotensin in all assays 
used. These results provide a basis for the 
development of renin and renin-substrate assays in 
a whole variety of vertebrates.
Other methodological problems and their relation 
to earlier work have been discussed in the appropriate 
sections. These include the need to validate the
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the assay standard (2.2.4.1,)} this study may have 
relevance to other assays using angiotensin IX as 
standard and the question is currently under 
investigation.
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3• Studios of the plasma concentration of renin- 
substrate in man.
Studies of the regulation and function of renin- 
substrate centre on the following problems. Firstly, 
it is undecided whether substrate is a rate-limiting 
factor in the renin-angiotensin system. This problem 
is approached in two ways, either by determining the 
Michaelis constant (Km) and the Vmax (see section 
2.1.1.10), or by demonstrating in vivo, whether 
changes in plasma renin-substrate concentration 
influence the circulating concentrations of angiotensin 
and, as a consequence, have a physiological role (see 
Fig.l). If the substrate concentration at Vmax is 
higher than in normal situations then the importance 
of understanding the factors that control renin- 
substrate is greater. Studies of these factors form 
the second aspect of this research.
The technique developed for the measurement of 
renin-substrate in man is described in part 2.2.4*1 
of this thesis. The method has since been used in 
several studies of the renin-angiotensin system, most 
of the assays being performed by the author. Because 
some of the results have been published a brief survey 
of the main findings only is given here and reprints 
of the publications are included as appendices to
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the thesis.
3*1. Situations in which the plasma concentration of 
renin-substrate is increased
Oral contraceptives are known to increase plasma 
renin substrate concentration. The observation was 
confirmed and it was further shown that the plasma 
concentrations of renin and aldosterone did not change 
(appendices 1 and 2).
Renin-substrate is also known to increase in 
normal pregnancy. This too was confirmed (appendix 3)* 
It was further shown that the plasma levels of renin and 
aldosterone did not correlate in individual pregnant 
women in contrast to other situations (e.g. Brown et al, 
1971)• Renin substrate data provided a possible explan­
ation for this. Although the plasma level of renin 
substrate also failed to correlate with aldosterone, 
the product of renin and renin-substrate did (Fig.38 
and appendix 3)« This suggested that variation in 
renin-substrate was influencing the amount of angio­
tensin formed by renin. Recent enzymekinetic evidence 
points in the same way (Gould and Green, 197l)*
Increased levels of renin-substrate have also 
been found in a woman with anorexia nervosa (Appendix 
4) and a man with severe hypertension and secondary
RELATIONSHIP of PRODUCT of PLASMA RENIN x RENIN-SUBSTRATE
To PLASMA ALDOSTERONE in NORMAL PREGNANCY
Renin Renin-substrate 
(units/l. ) (ng deca angio/ml )m
300,000-
200,000-
•  During Pregnancy 
XPost-Partum
n = 32 
r = 0-54 
P C  0*01
100,000-
1306020 40
Plasma aldosterone 
(ng/lOOml)
Fig.38. (From Weir, Paintin, Robertson, Tree, 
Fraser & Young* 1970).
hyperaldosteronism (Appendix 5)«
3*2. Situations in which the plasma concentration 
of renin substrate is decreased.
Decreased values were found in Addison!s disease 
in occasional cases with cardiac failure (Davies et al, 
to be published), in the nephrotic syndrome (Medina et 
al 1972) and in two children with an unexplained form 
of hypokalaemic alkalosis (Desmit et al, 1970).
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4*0. Comparative physiology of the renin— 
angiotensin system.
Biochemical and technical aspects of the renin 
angiotensin system have been discussed in parts 
1 and 2 of this thesis.
The fourth section consists of a 
consideration of the literature on the comparative 
aspects of the renin-angiotensin system (4.l) and 
a description of several studies on the 
comparative physiology of renin and angiotensin 
(4.2.1. - 4.2.6.). The techniques developed 
specifically for these studies are described 
in part 2 of the thesis.
4.1. Previous work on the comparative
physiology of renin and angiotensin
Understanding of the renin-angiotensin system 
is based almost entirely on studies in man and 
laboratory mammals. Because renin seems most 
closely related to the regulation of sodium 
balance, and because sodium balance undergoes 
more extreme physiological changes in lower 
vertebrates, neglect of these groups is
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particularly unfortunate. A comparative study of* the 
evolution of the renin-angiotensin system in 
vertebrates might also be particularly revealing 
because the mechanisms controlling salt and water 
balance have evolved in quite different ways in the 
various vertebrate classes.
4.1.1. Studies in mammals
Work on renin and angiotensin in man and 
laboratory animals has been discussed both in part 1 
and 2 of this thesis and in reviews by Davifs (1964, 
197l)» Brown et al (1966), Peart (1965)/ Page and 
McCubbin (1968), Lee (1969)* Coghlan et al (l97l) and 
Ferrario et al, (1972).
Capelli and his colleagues (1970) measured.renin 
and glucose-6-phosphate dehydrogenase in the kidneys 
of a variety of mammals and whilst renal renin was lower 
in the desert rat (Dipodotnys perblandure) than in the 
hamster (Mesocricetus auratus) and the white rat 
(Rattus norvegicus), the G-6-phosphate dehydrogenase 
staining of the macula densa was more intense. The 
authors were unable to interpret the observation.
Eichelberger et al (l94o) showed that renin­
like activity was present in the kidney of the
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dolphin (Tursiops truncatus), and, as will be 
described in section 4.2.1. of this thesis, 
renin was detected without difficulty in the 
kidney of the porpoise (phocaena phocaena)• Malvin 
and Vander (1967) demonstrated that the plasma 
renin activity in 5 species of Cetacea was 
similar to that of other laboratory mammals. 
However, the manner in which the Cetacea 
regulate salt and water balance is clearly 
different from terrestrial mammals; a water­
load administered through a stomach tube does 
not induce a diuresis although after a meal, 
glomerular filtration rate, renal plasma flow and 
urine flow increased 24-fold in the dolphin 
(Tursiops gilli) (Malvin and Rayner, 1968). 
Unfortunately, renin measurements were not made 
during these experiments.
The response of the marsupial Trichosurus 
vulpecula to stimulation of the renin- 
angiotensin system was found to be similar to 
that of eutherian mammals (Reid and MacDonald 
1969 a &b)x plasma renin activity was increased 
by low sodium diet, by mercurial and non-mercurial
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diuretics, and by haemorrhage. Sodium chloride 
loading reduced renin activity. Increased 
granulation of the juxtaglomerular cells was 
noted during sodium deficiency. The clearance of 
injected renin from plasma was found to be similar 
to that in the dog (Canis f ainiliaris) .
In another marsupial, the North American 
opossum (Didelphis virginiana), injected renin 
stimulated cortisol, corticosterone and aldosterone 
whilst sodium depletion caused increased juxta­
glomerular granulation. The properties of 
renin were similar to those in the eutherian mammal, 
the enzyme being heat-labile non-dialysable, 
and stable at a pH of 2.6 (Johnston et al, 196ja.) .
Juxtaglomerular granules have been identified 
in the embryonic mesonephros of the hog (Sus scropa 
domesticus) and it was only after degeneration of 
the mesonephros that the quantity of granules 
increased in the metanephros (Sutherland and 
Hartroft, 1968), Bing and Kazimierczak (1964) 
however, were able to bioassay renin in the 
subscapular zone of the kidneys of new-born pigs,
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where afferent and efferent vessels were absent*
Xt can be concluded on good grounds, therefore, 
that renin is widely distributed in mammals 
and that it bears a relatively consistent relation 
to sodium metabolism,
4.1,2, Studies in birds
Renin was first demonstrated in birds by 
Schaffenburg and his colleagues in i960. Renal 
extracts from the chicken (Gallus domesticus) 
produced angiotensin-like material when incubated 
with homologous plasma. Also in the chicken,
Taylor et al (1970) demonstrated aldosterone in 
adrenal venous blood, as did Phillips and 
Chester Jones in 1957 after administering ACTH. 
However, Taylor and colleagues were unable to 
show a stimulant effect on aldosterone of 
injection of renin or ACTH yet, after sodium 
depletion, renal renin and juxtaglomerular index 
increased. The juxtaglomerular granules were 
smaller and sparser than in the mammal, A macula 
densa was also identified. The cells of the 
avian macula densa have been described (Ogawa and
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Sokabe, 1971) as being structurally transitional 
between those typically seen in mammals and 
ordinary cells of the distal tubule. McKelvey 
(1963) also observed granular cells in birds.
The adult budgerigar (Sutherland, 1966, referred 
to in Sutherland and Hartroft, 1968) showed 
juxtaglomerular granulation, but staining was 
not present in the afferent glomerular arteriole 
in either the mesonephros or the metanephros 
of the embryonic kidney. In the pigeon (Columba 
oenas), Capelli et al (1970) showed that renal 
renin reacted with ox substrate to form angiotensin. 
A structure analogous to the macula densa was 
recognised although the glomerulus seemed poorly 
developed. Studying the pigeon and duck (species 
unstated), Holmes et al (1969) demonstrated 
an increase in plasma renin activity following 
haemorrhage and in the pigeon a rise of blood 
pressure after injection of angiotensin II. 
Hypophysectomy in the pigeon led to a 4-fold 
increase of plasma renin activity which was 
subsequently reduced by ACTH.
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4.1.3« Studies in reptiles
Renin has been demonstrated in the kidney 
tissue of a brackish-water turtle (Malaclemys sp.)
(Kaley and Donshik, 1965) a fresh-water turtle 
(Chrysemys sp.) (Connell and Kaley, 1964; Capelli 
et al, 1970), and the desert tortoise (Gopherus 
agassizi) (Capelli et al, 1970). McKelvey (1963) 
also observed granular cells in reptiles,
Nothstin© and colleagues (l97l) have 
demonstrated the presence of the renin-angiotensin system 
in a fresh—water turtle (Pseudemys sueanniensis) 
in which kidney extracts were vasopressor and 
stimulated corticosterone secretion. They could 
not detect aldosterone in this turtle but could 
in the crocodile (Caiman sclerops). However, 
crocodile kidney extract did not influence steroid 
secretion into postcaval vein plasma; nor was 
renin identified with certainty,
4,1.4, Studies in Amphibia.
Juxtaglomerular granules were observed by 
McKelvey (1963) in amphibians. The macula densa 
has been identified in the juxtaglomerular cells
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of tho American bull—frog (Rana catesbeiana), and 
granules were distributed at various sites along 
the afferent glomerular arteriole (Hartroft, 1966). 
The juxtaglomerular apparatus in the ne|f?t 
(Triturus cristatus) was composed of cells from 
the media of the afferent giomerular arteriole 
which contained granular cells, and cells of the 
intermediary tubule. However, typical macula densa 
and lacis cells were absent (Bellocci et al, 197l)* 
The macula densa was also previously noted by 
Capelli et al (1970) in Rana pipiens.
Capelli and associates (1970) also found 
that renin was demonstrable in renal extract 
and decreased to undetectable levels when the 
frogs were acclimatised to 0 .02$ sodium chloride 
solution. In 1968 Ulick and Feinholtz showed that
aldosterone secretion in the bull-frog was
stimulated by sodium depletion but not by 
injection of Asn 1 Val 5 angiotensin II. Taylor 
and Davies (l97l) also failed to stimulate 
aldosterone in the bull-frog. with Asn 1, Val 5
angiotensin II and also carp renin even with
165
quantities that increased the blood pressure* 
However, the angiotensin-like product from the 
reaction of carp kidney extract with carp 
plasma did increase aldosterone and corticosterone 
secretion and blood pressure in the bull-frog*
In the hypophysectomised bull-frog, on the other 
hand, intravenous infusion of bull-frog renin 
did increase aldosterone secretion (Johnston et al, 
1967b).
Asn 1, Val 5 angiotensin II does affect 
renal function having an antidiuretic and 
antinatriuretic effect (Coviello, 1969# 1970) in 
Bufo paracnemis, Similar results were previously 
obtained by Henderson and Edwards (1969) with 
Xenopus laevis when Asn 1, Val 5 angiotensin II 
was infused in saline. This effect was 
reversed in animals maintained in distilled watex. 
More recently, Nolly and Fasciolo (l971b) 
studying Bufo arenarum were unable to demonstrate 
changes of renal renin as a result of peritoneal 
dialysis after treatment with the natriuretic 
diuretic furosemide, or exposure to distilled 
water or sodium chloride solution (0*11 — 0*35 M)•
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Nolly and Fasciolo (1971&) also found renal renin 
concentration to be higher in small toads than 
large ones. There was twice as much renin in 
male kidneys as in females, although plasma 
renin-substrate values did not differ 
significantly.
4.1.5* Studies in fish
The presence of renin in the kidney of 
certain fish has been disputed. Some workers have 
been able to demons fcrate the enzyme in all or 
most of the fish studied (Chester Jones et al,
1966; Mizogami et al, 1968, Capelli et al,
1970; see also section 4.2.I.I.). Others were 
less certain of its presence particularly 
in aglomerular teleosts, (Friedman and Kaplan,
1942} Friedman et al, 1942} Kaley et al, 1963} 
Connell and Kaley, 1964). One possible 
explanation for this discrepancy is that renin 
is present in the kidneys of all fish, that there 
is more in the kidneys of fresh-water fish and that 
the low levels present in glomerular and aglomerular 
salt-water fish were undetectable by some of the 
cruder methods in which angiotensinase inhibition
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.had not been achieved.
From a morphological standpoint, Capreol 
and Sutherland (1968) found that there was no 
macula densa in fish. They (quoting Sutherland, 
1966) were also unable to find granular 
juxtaglomerular cells in the Agnatha (lamprey 
and hagfish, species unstated)• McKelvey 
(1963) could not identify juxtaglomerular 
granular cells in elasmobranchs (species unstated). 
This evidence was supported by Bohle and 
Walvig (1964) who studied Acanthias vulgaris, 
and by Capreol and Sutherland (1968) in Raja 
laevis. Granular cells have been observed in 
a wide variety of Osteichthyes (Bohle and 
Walvig, 1964; Bulger and Trump, 1965; Capreol 
and Sutherland, 1968; Mizogami et al, 1968).
An increase in the amount of renin in 
kidney tissue following reduction of environmental 
salinity has been demonstrated in the aglomerular 
Opsanus beta and in the glomerular kidneys of 
Alossa sapidissima, Pomelobus pseudoharengus 
(Capelli et al, 1970) and Anguilla japonica and 
Tilapia mossambica (Sokabe et al 1968). Also in
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Anguilla .japonica juxtaglomerular granularity 
appeared to decrease in the sea water 
environment. However, in Cymatogaster aggregata 
juxtaglomerular granularity was increased with 
increasing salinity (Lagios, 1968). In accord 
with this, renal renin concentrations were 
found to be higher in the marine teleosts 
Tautoga ap. and Paralichthys sp. when compared 
with the freshwater teleosts Carassius sp. 
and Ameiurus sp. (Kaley et al, 1963; Kaley and 
Donshik, 1965).
In a study of Tilapia mossambica. Malvin and 
Vander (1967) found no differences of plasma 
renin activity in fish kept in high and low 
salinity.
Injections of Asn 1, Val 5 angiotensin in the 
eel (Anguilla anguilla) leads at first to an 
increase of urine flow and clearances of PAH 
and inulin, and then to an antidiuresis (Chester 
Jones et al, 1969)* Injected Asn 1, Val 5
angiotensin II and eel renin.also raises the blood
/
pressure of the eel (Chester Jones et al, 1966).
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A possible role for the corpuscles of* Stannius 
in the regulation of blood pressure and sodium 
balance is discussed in papers by Chester Jones 
et al (1966) and Sokabe et alf (1968),
In summary, renin or renin-like enzymes 
have been extracted from the kidneys of fish, 
reptiles, amphibians, birds and mammals*
A juxtaglomerular apparatus, the probable site 
of renin storage, has been identified in most 
of these groups* A clear relation has been 
demonstrated in mammals between the loss of sodium 
and water and an increase of renin; by 
stimulating release of sodium-retaining steroids 
from the adrenal cortex, the increase of renin 
would tend to compensate for the sodium loss*
A similar mechanism may be at work in birds and 
amphibians, although the evidence is scanty*
In fish the picture is confused* Although renin is 
certainly present in the kidney of fish it is not 
clear whether adaptation to a low salt intake is 
associated with an increase or with a decrease 
of renal renin. A change from a high to a low- 
salt environment in fish is associated not only
with a tendency to sodium loss, but also with 
water influx, a situation dissimilar from 
sodium and water depletion in the mammal•
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4•2• New studies of the comparative
aspects of renin and angiotensin
4,2.1. Renin in vertebrate kidney tissue.
Using the methods described on page 106* 
extracts from a wide variety of vertebrate kidneys 
were tested for renin both by direct injection 
and indirectly after incubation with ox substrate. 
Angiotensinase activity was shown to be controlled 
by DP in the incubation experiments (table 12).
Where a positive result was obtained, the 
progressive formation of angiotensin during 
incubation was demonstrated by assay of aliquots 
taken at different times from the incubation mixture.
Excepting rabbit kidneys, which contain a 
large amount of renin the results are expressed as 
the concentration of angiotensin-like material 
present in the mixture after 16 hours incubation. 
Although the original extracts were prepared in an 
identical manner (200 mg kidney tissue/ml of extract), 
different dilutions of extract were used in the 
incubation depending on their renin and angiotensin— 
ase content. Generally, the dilution was greatest 
when the angiotensinase content was high and the
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Table 12 Renal renin assay and renal angio t >ensinase Inhibition by DP, in vertebrates.
Species Direct Assay 
** 1
Indirect Assay Angiotensin II recovered at 62 hr.
PISCES
Scomber scombrus (Mackerel)
Gadus morhua (Cod)
Salmo trutta (Sea trout)
Anguilla anguilla (Eel)
AMPHIBIA
Rana temporaria (Frog)
REPTILIA
Vipera russelli (Russells viper)
? (Porters giant tortoise)
? (Blue spiny lizard)
Testudo radiata (Radiated tortoise)
AYES
Balearica pavonina (African crowned crane) 
Spheniscus humboldti (Humbolts penguin)
Rhea americana (Rhea)
Pavo cristatus (Peafowl)
? (Semipalmated goose)
MAMMALIA
MARSUPALIA
Protemnodon dorsalis (Pretty-face wallaby) 
Macropodus sp. (Wallaby)
? (Silver grey phalanger)
Thylogale sp. (Short-tailed pademelon)
PRIMATA
Comopithecus hamadryus (Sacred baboon)
Cercopithecus aethiops sabaeus (Green monkey) 
Erythrocebus patas (Patas Monkey)
Homo sapiens (Human)
EDENTATA
Myrmecophaga tridactyla (Giant anteater) 
Cyclopes didactylus (Dwarf anteater)
PHOLIDOTA 
Manis sp. (pangolin)
LAGOMORPHIA 
Oryctolagus cuniculus (N.Z.—white rabbit) 
RODENTIA
Myocaster coypus (Coypu) .
Hattus norvegicus (Norway rat, Wistar strain)
Extract
injected
mg.
Renin 
response 
mm . Hg
Extract 
mg/ml.
20 & 40 Unlike r e n i n 1.8
i *i ti it i 1.8
i ti n n it 1.8
ii i n n ti 1CC•H
ti i it n it 0 • 00
n i it ii ti 1.8
ti i i it ti 0.8
it it n ii ii 1.8
ii i i it i 1.8
20 U5) 1.8
20 (22) 0.8
20 3°) 1.8
20 (2°) 0.8
20 (11) 1.8
40 18 1.8
40 20 0.8
40 14 1.8
40 10 0.8
40 18 1.8
40 U n l i k e  r e n i n 0.8
1 unit 3 0.4
20 j 3 1.8
-j - 1.8
20 26
00•0
4o 25 0.4
40 32 1.8
2 28 0.4
nM A II 
at 16 hr
Extract 
. mg/ml
$ A II Extract 
mg/ml.
% A 1
19 0.5 100 3.0 50
19 O.67 85 6.7 <10
780 0.4 100 4.0 10
33-213 1.0 76 1 <10
<19 1 60 1 <10
19 it 100 1 15
19 1 40 it <10
29 1 80 1 10
29 n 90 ti <10
39 1 100 1 15
44 1 40 it <10
19 1 80 ti <10
19 ti 20 n <10
44 1 70 i <10
107 1 75 ti <10
24 1 40 ti <10
242 1 80 ti 20
- 1 50 ti <10
146 1 <10 it <10
39 n 70 it * <10
19 1 <10 it <10
15 o.oo4 90 0.04 60
63 0.4 80 4.0 30
680 1 90 ti 60
340 n 50 1 <10
68(lhr) 1.6 . 100* - -
160 0.4 80 4.0 <10
78O 1 100*
t 90*
Table 12 (continued 
Species
173
Direc t As Si Indirect Assay io Angiot ensin II recovered at 62 h
tract
. jected
**Rt
re
mn
nin Extract 
sponse mg/ml 
i.Hg
nM A II 
at 16 hr.
Extract
mg/ml
$ A II Extract
mg/ml
io a ii
10 L.8 0.4 1070 0.4 100* 4.0 90*
40 2.8 0.4 29 0.004 90 0.04 60
2 Si2 0.4 1450 0.4 100 4.0 70
2 r,63 0.8 680 it <10 it <10
10 r-45 0.8 68 it 20 i <10
20 41 0.4 97
j
it 90* it 80*
20 i9 1.8 390 i» 70 i <10
20 5 0.4 242 it 100* 1.6 100*
20 0 0.4 68 ti 93* 1.6 100*
20 j9 1.8 233 it 70 4.0 <10
20 i6 0.8 63 i 40 i <10
20 0 1.8 291 it 80 ii 10
mg
CETACEA
Phocaena phocaena (Porpoise)
CARNIVORA 
Canis familiaris (Domestic dog)
Thalarctos maritimus (Polar bear)
Herpestes urva (Crab-eating mongoose)
Arctictis binturong (Binturong)
PINNIPEDIA 
Halichoerus grypus (Grey seal)
TUBULIDENTATA 
Orycteropus afer (Aardvark)
ARTIODACTYLA 
Choeropsis liberiensis (Pygmy hippopotamus)
Camelus sp. (— Camel)
Laraa guanicoe (Guanaco)
Bos taurus (Domestic ox)
Ovis musimon (Mouflon)
Notes:
1. * = % angiotensin II recovered after 48 hours, not, as in other experiments, 62 hours.
2. ** s= The mean response to two or three injections in different rats.
3. Figures in parentheses refer to vasopressor responses that vere not entirely like renin (See Fig. 12)
For Anguilla anguilla, indirect assay data are from Figure *3 and the angiotensin recovery data represents the mean recoveries
from six individual kidney extracts, incubated for 20 hours.
5« In control samples without DP, angiotensin was undetectable ( <10^) after hour.
i . -;v\ J'JTv RbsbH
period of incubation shortest when renin content 
was high as in the rabbit (table 12).
The positive findings were as follows*—
4.2.1.1. Pisces
I. The presence of renin in renal extract
A renin-like enzyme was detected in large 
amounts in kidney tissue of the sea trout and 
eel and in small amounts in kidney tissue from 
the cod and mackerel (table 12). As described 
on page 83 9 fish kidney extract also contained 
a diffusible, heat—stable, pressor material.
II. Location of renin in the kidney of fish 
The data quoted above were derived from
extracts of entire kidneys. An incidental 
observation made on one eel and confirmed in a 
single sea trout, suggests that renin may not be 
distributed symmetrically in the teleost kidney.
There are variations in the morphology and 
anatomy of the kidney in the adult teleost 
(Ogawa, 1961 and 1962} Hickman and Trump, 1969). 
“Head”, anterior and posterior divisions of the 
kidney were recognised here in the sea trout and
anterior and posterior divisions in the eel (Fig.
/
39). S octions of kidney tissues were therefore 
taken from these regions in the sea trout and eel.
As can be seen in table 13» most renin was found 
in the posterior kidney.
Ill• Association of renin with glomeruli in the eel 
In a further preliminary experiment, an eel 
was anaesthetised with M.S. 222 and, using the 
method of Nash (l93l)» 20 ml of Prussian Blue 
(2$ potassium ferrocyanide solution and 2$> 
ferric ammonium citrate in distilled water) was 
injected into the exposed ventral aorta in a 
cephalad direction. The kidney was then examined 
under a dissecting microscope (magnification x 20 ) 
and 16 single glomeruli were teased out as 
described by Brown et al (1965)• The glomeruli 
were stored at -20°. On thawing, glomeruli were 
incubated singly or in groups of up to 7 at 37° 
with 2 ml of ox substrate. The angiotensin formed 
was assayed using angiotensin II as standard.
The results are expressed as the amount of 
angiotensin present after 2& hours incubation* A
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SEA TROUT
Head' Anterior' Posterior — KIDNEY REGIONS 
i i  i i
EUROPEAN EEL
A n te rio r' ’Posterior' — KIDNEY REGIONS
Fig.39. Diagramatic representation of zones of fish 
kidney extracted for renin (see table 13)*
Kidney
region £ e 1 Sea Trout
Section Angiotensin Section Angiotensin
(Fig.39) II nM /hr,. (Fig.39) II nM/hr.
Head / / 1 10
Anterior A 10 2 39
B 10 3 290
Posterior C 144 4 290
D 258 3 290
£ 258 / / 1
Table 13* Renal renin assay of zones of fish kidney.
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‘ detectable amount of angiotensin was formed in all' 
instances (Table 14), the rate of angiotensin 
formation being comparable with that obtained with 
single glomeruli (Brown et al, 1965).
4.2.1.2. Amphibia 
Renin could not be detected by direct or 
indirect assay in the kidney of Rana temporaria.
4.2*1*3* Reptiles and birds 
A small amount of renin-like activity was 
demonstrable in each of the nine reptiles and 
birds when renal extracts were incubated with 
substrate. On direct injection some of the 
extracts produced a rapidly acting pressor response.
4.2.1.4. Mammals 
Renin was demonstrable both by direct and 
indirect assay in most mammalian species studied. 
Particularly large amounts were found in the 
rabbit, polar bear and the porpoise. It may be 
relevant that the porpoise was pregnant at the time 
of death; plasma renin concentration is known to 
be high in human pregnancy (Brown et al, 1963)*
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TABLE 14.
RENIN CONCENTRATION IN EEL GLOMERULI
No. of glomeruli. Angiotensin (nM)
at 26 hours.
1 10
1 x 34
1 15
2 19
4 36
7 36
See text for the method of* renin assay.
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' 4.2.1.5* Discussion
The positive finding in this study is that a 
renin-like enzyme has been identified in kidney 
extracts of a wide*variety of vertebrates.
Taken with earlier work (page 157to170 ) these 
observations make it likely that renin is 
present in all vertebrate classes.
As stressed earlier, (page 36 ) negative 
findings using this technique do not indicate 
that renin is absent in a particular species.
Renin could not be demonstrated in kidney tissue 
of the frog for example. This is most likely 
to be a technical failure since renin is known ' 
to be present in other amphibian kidneys ( page 1^3)
The observation on fish renin described above 
suggests that at least part of the renin in the 
kidney of the eel is associated with the 
glomerulus. Similar observations have been made 
in mammals (see review by Brown et al, 1968j 
Cook, 1971), but not to date in fish. The 
observation is of interest in relation to the 
possibility that renin may regulate glomerular
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filtration and the flow of blood through the 
glomerulus (see Brown et al, 1972). Large 
changes of glomerular filtration and renal blood 
flow occur in fish on changing from a fresh 
water, to a marine environment (see page 192).
As will be discussed renin is suitably placed to 
mediate or contribute to these effects in the 
fish. The possible significance of these 
findings is discussed on.page 189.
4.2.2. Renal renin and plasma renin-substrate 
in eels adapted to sea water and 
fresh water environments.
The source of eels aiid the nature of their 
accommodation during the experiments are 
discussed on page 51* Initially, all eels had 
been adapted to fresh water. Nine were further 
maintained in fresh water and nine - matched 
individually for weight and length - were 
adapted to sea water by increasing the salinity 
of their environment gradually over 4 days to 
a specific gravity of 1.022. This was achieved 
by adding an amount of "Meersalz,v (630 gm) 
every 12 hours, which was sufficient to raise
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the specific gravity by 0,0028. After the 
period of adaptation the eels were maintained in 
sea water for between 9 and 31 days.
Matched pairs of eels were studied at the 
same time, between 2 and 3 being present in a 
tank at any one time. The system of matching 
was necessary because the experiment lasted 
from July to November (1970) and water 
temperature varied from 7 to 17°• Also, the 
hours of daylight were decreasing during the 
course of the experiment.
At the conclusion of the experiment a 
sample of blood was taken (see page 53)
for renin substrate measurement, the eels were
killed and the kidneys were removed, weighed 
and extracted for renin.
4. 2 . 2 • 1. Renal renin 
There was no significant difference in 
renal renin content in the eels adapted to fresh 
water and sea water environments (students* t =
0.25, p = 0.8 - 0.9)* Nor was there a' 
significant difference when data from the
182
individual pairs were assessed by paired t test 
(t « 0.23, P = 0.8 to 0.9, Table 15).
4.2.2.2. Plasma concentration of 
renin-substrate.
The results illustrated in Table 15 suggest 
that adaptation to sea water is associated with 
a decrease of plasma concentration of renin- 
subs trate. In seven of the nine matched pairs 
substrate concentration was lower in the sea 
water eel. However, these differences did not 
achieve statistical significance at the 5$ 
level (students t = 1.45, P = 0.1 to 0.2; paired 
t test, p = 0.05 to O.l).
4.2.2.3. Discussion
The experiments described above have shown 
that adaptation to sea water in the eel is not 
associated with any significant change of renal 
renin. It is also likely, but of only marginal 
statistical significance, that the plasma 
concentration of renin-substrate decreases in 
these circumstances.
The relation of these findings to earlier work 
and their significance are discussed on page 191.
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4.2.3* Preliminary study of the pressor material' 
in extracts of the corpuscle of Stannius 
in the eel.
In a previous study (Chester Jones et al, 1966) 
it had been shown that saline extracts of the 
corpuscle of Stannius from the eel, produced a 
prolonged pressor response when injected intra­
venously in the rat (Figure 4 o ) .  The possibility 
that the response' was due to renin was considered, 
although it was apparent that the response 
produced by renal renin was briefer in duration. 
Further studies were begun recently and preliminary 
results are included here.
4.2•3•1• Effect of corpuscle extract in the 
nephrectomised rat.
One possible explanation for the slow pressor 
response to injected corpuscular extract is that 
it stimulates renin release from the nearby kidney 
(the corpuscle is closely apposed to the surface of 
the kidney). To investigate this, a corpuscle 
extract was tested on 3 nephrectoraised rats.
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F_ig.40. The vasopressive response to 19 mg of 
extracted corpuscles of Stannius after i*v. 
Injection Into the nephrlc rat at the time 
Indicated by the arrow.
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BP 
mm.Hg
3 0
_Fig»4l. The vasopressive response to 22 mg of 
extracted corpuscles of Stannius after i.v. injection 
into the anephric rat, at the time indicated by the 
arrow.
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Pressor responses were obtained on 2 of these 
occasions; the most marked, illustrated in figure 
4l, being similar to responses seen in test rats 
with intact kidneys* It is unlikely, for these 
reasons, that the corpuscular extract acts by 
stimulating renin release from the kidney*
4.2.3.2. Comparison of corpuscle extracts 
and kidney renin*
Dialysed extracts of eel kidney injected into 
the anaesthetised rat produced little or no 
pressor response* Incubation of the same extract 
with ox substrate in the presence of DP as an 
inhibitor of angiotensinase (page 85 )> led to
rapid production of angiotensin-like pressor 
material as described earlier (page 85),
Also injected into the rat, a corpuscle 
extract produced a pressor response on 3 of 3 
occasions to 11 or 22 mg extract* The time course 
and height of these responses when present, 
was always considerably greater than the pressor 
effect with renin—containing extracts*
Incubation of the same extracts of corpuscle with
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ox substrate or eel plasma (Fig 42) and DP as
above produced an amount of angiotensin-like
material which was difficult to differentiate
from the blank containing ox substrate or eel
plasma and DP incubated alone*
This experiment suggests that the corpuscle
pressor effect is not attributable to an enzyme
which reacts in a renin-like manner with ox or eel
renin-substrate•
A further possibility tested was that the
extract contained an accelerator of the renin—
substrate reaction* This was investigated by
*
adding to an eel renin-renin substrate 
incubation an amount of corpuscle extract which on 
incubation with substrate had no pressor effect*
No augmentation of the renin—substrate reaction 
occurred when the corpuscle extract was added 
(Fig 42).
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Fig«42. Effect of corpuscle of Stannius extract (4 mg/ 
ml) on the reaction of eel renin (l mg kidney/ml)with 
eel substrate (20% v.v. eel plasma). 0 = eel substrate 
alone, X ■ eel substrate + corpuscle extract, A = eel 
substrate + eel renin, 0 a eel substrate + eel renin 
+ corpuscle extract. Each point represents the mean of 
duplicate assays.
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4.3. Discussion of data obtained
The wide distribution of renin amongst the 
vertebrate classes
Together with earlier studies (pages 157- 170 ) 
the results obtained in this thesis suggest that 
renin is present in the kidney of all classes of 
vertebrate. Because this in turn suggests that 
the renin-angiotensin system did not develop 
during the evolution of mammals,birds, reptiles 
or amphibia, it is unlikely that the enzyme is 
specifically involved in a mechanism peculiar to 
one of these classes. Thus, although renin can 
increase the osmolality of urine (see Page and 
McCubbin,1968), it is unlikely that renin evolved 
primarily in relation to the mechanism 
responsible for increasing urine concentration 
above that of plasma, because birds and mammals 
only have this capacity.
A similarly broad distribution of renin is 
found amongst warm— and cold-blooded vertebrates 
regardless of whether they are carnivorous, 
omnivorous or herbivorous or whether their habitat
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is terrestrial or aquatic. It is unlikely 
therefore that these were important selective 
factors in the evolution of the renin-angiotensin 
system.
4.3.2. Role of renin in vertebrates
Opinions on the physiological or pathological 
role of renin are divided. Because at least six 
distinct pharmacological effects have been 
produced by injection of renin or angiotensin, it 
is sometimes assumed that similar effects occur 
physiologically or pathologically. Evidence on 
this point is scanty and almost exclusively 
obtained from studies in man and laboratory 
mammals (see Brown ot al, 1971b).
For example, injected renin and angiotensin 
have distinct effects on renal function, leading 
to marked changes in the volume and sodium content 
of urine. The mechanism of these effects is not 
understood, though it is likely that changes in 
both glomerular filtration and tubular reabsorption 
are involved. It is also possible that endogenous 
renin and angiotensin act
locally within the kidney of the mammal (Brown et 
al, 1970)* The present finding of renin in 
close association with the glomerulus of the fish 
(4.2.1.1.) is relevant because large changes of 
glomerular filtration occur in migratory fish 
on changing from a fresh-water to a sea-water 
environment (Hickman and Trump, 1969). Although 
renin is suitably located anatomically to produce 
these changes by direct vasoconstriction of 
either afferent or efferent arterioles, no 
significant changes of renal renin were observed 
when the eels were acclimatized to sea water. 
Although the.changes of renin substrate observed 
in the present experiments were significant only 
at the 10$ level, they were in a direction which 
would have led to a greater amount of angiotensin 
being formed in the fresh water environment•
Taken together the present observations on 
substrate and the experiments of Sokabe et al (l966, 
1968) suggest that a gradual decrease of activity 
in the renin-angiotonsin system occurs during 
acclimatization to a sea—water environment. For
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this to be linked, with the decrease of glomerular 
filtration which occurs at this time the 
predominant effect of renin and angiotensin in 
the kidney would have to be that of vasoconstriction 
of the efferent arteriole. Clearly, further study 
is needed.
Studies here (Table 12) and elsewhere, on 
renin in the kidneys of different species of fish 
show that there was generally more renin 
extractable from those in fresh water from those 
in sea water (Capelli et al, 1970; Mizogami et al, 
1968), This is likely to mean that there is more 
renin in the fresh water fish, but for reasons which 
are discussed on page 16 there are other possible 
explanations for the difference and a proper 
calibration of techniques is needed before a 
valid comparison can be made.
Migrating fish have a lower glomerular 
filtration rate and a lower rate of sodium 
excretion from the kidney, when acclimatized to 
sea water. Thus, the kidney does not help to 
correct the potential disturbance of sodium 
balance which confronts the sea water fish, and
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the excess sodium is eliminated mainly by way of 
the gills (see reviews by Conte, 1969 and Hickman 
and Trump, 1969)* If angiotensin does regulate 
glomerular filtration under these circumstances, 
its vasoconstrictor effect would have to be 
exerted on the efferent glomerular arteriole#
4#3#3# Stimuli to renin.
The stimuli to renin release in the mammal 
have not been identified. Although there is 
little doubt that reduction of blood volume or 
loss of sodium can lead to renin release, the 
way in which this occurs is far from clear# 
However, with a few exceptions reduction of plasma 
volume and loss of sodium occur together in the 
mammal (see review by Brown et al, 1966)#
The migrating eel may represent an 
interesting exception in the fish# On changing 
from fresh-water to sea—water, the eel is 
confronted with a reversal of its osmotic 
environment# In fresh water, there is a tendency 
to a sodium loss and influx of water, and in the 
sea, the eel is exposed to sodium influx and water
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loss. Since sodium gain would increase total 
body sodium and water loss decrease plasma 
volume, a study of the renin in the migrating 
fish could increase understanding of the stimuli 
to renin release.
4.3»4. Renin and aldosterone in fish
The ability of renin and angiotensin to 
stimulate aldosterone secretion in mammals is 
well-known and it is likely that sodium balance 
in the mammal is at least partly controlled by 
a feed-back mechanism involving renin and 
aldosterone (see Brown et al, 1966). The status 
of aldosterone in fish is less certain. The 
subject is reviewed by Chester Jones et al (1969) 
and Idler (1968) and is briefly re-stated here: 
Phillips et al (1959) isolated small quantities _ 
of aldosterone from the plasma of the Pacific 
salmon (Oncorhynchus nerka), although Idler, 
working with blood from the same species at the 
same stage of maturation was unable to confirm 
the observation. Similarly, Sandor et al 
(1966, 1967) were unable to demonstrate the
195
ability of adrenocortical tissue in the eel 
(Anguilla anguilla) to synthesise aldosterone, 
and subsequently Hargreaves and colleagues
(1970) similarly failed with Poecilia 
latipinna and Salmo gairdneri. However,
Truscott and Idler (1968) showed that adrenal 
tissue of the herring, (Clupea harengus harengus) 
could form aldosterone from corticosterone* 
Subsequent studies have failed to identify 
aldosterone in the Agnatha (Weisbart and Idler, 
1970) t Selachii (Simpson and Wright, 1970)
and the Chondrostei (idler and Sangalang 1970)•
As Idler suggests, the technical difficulty in 
identifying the extremely small amounts of 
steroid present could explain this apparently 
conflicting evidence. Alternatively another 
steroid hormone may regulate sodium in fish.
For example Ball and colleagues (l97l) have 
provided evidence to suggest that cortisol under 
ACTH control may regulate the transfer of gut 
and possibly gill electrolytes during the migration 
of Anguilla anguilla from fresh-water to sea­
water.
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If a function of' renin and angiotensin is 
to stimulate the secretion of aldosterone or 
other steroids, renin could act as a local 
tissue hormone. The site of adrenal steroid 
formation in the fish, the interrenal, is embedded 
in the wall of the posterior cardinal sinus 
upstream of the renin-containing posterior 
kidney. Renin released from the kidney would 
enter the cardinal sinus and it may be that 
angiotensin formed in venous blood could 
stimulate interrenal steroid production without 
recirculation in arterial blood, the whole system 
acting via a "portalM circulation. In fact 
renin may act as a local hormone in amphibians 
too, since Belocci and colleagues (l97l) have 
found interrenal tissue to be located close to 
the glomerular arteriole and renal tubule. The 
possibility that renin and angiotensin acting 
as a local tissue hormone may stimulate steroid 
production has been discussed (Brown et al, 1968).
The ability of injected aldosterone to 
affect sodium transport mechanisms in fish is 
more certain (see review by Chester Jones et al,
1969)* Aldosterone is capable of* correcting 
the defective sodium transport mechanism in 
the gill of the adrenalectomised eel. It may 
be, therefore that release of aldosterone 
(or some other mineralocorticoid) is 
stimulated by renin in the fresh-water fish.
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